hg_76512.1

Basic information about the TSS

---

TSS ID: hg_76512.1 Species: human Chr: chr6		Start: 159691773 End: 159691789 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000541573.5 Distance: -289 GeneID: 6648 HGNC/MGI_ID: HGNC:11180 UniProt_ID:

Gene_name: superoxide dismutase 2 Gene_symbol: SOD2 Gene_synonyms: GClnc1 Gene_source: HGNC:11180

TATA-Box annotation

---

Distance to TSS:	1460
Nearest PromoterID:	NM_001322814
Entrez ID:	6648
Nearest Unigene:	Hs.487046
Nearest Refseq:	NM_000636
Nearest Ensembl:	ENSG00000112096
Gene Name:	superoxide dismutase 2
Gene Alias:	IPO-B|IPOB|MNSOD|MVCD6|Mn-SOD
Gene Description:	superoxide dismutase 2
Gene Type:	protein-coding
CpG%:	0.005
GC%:	0.318408
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SOD2 p2@SOD2 p3@SOD2 p4@SOD2 p5@SOD2 p6@SOD2 p7@SOD2 p9@SOD2 p10@SOD2
Sample		p1@SOD2	p2@SOD2	p3@SOD2	p4@SOD2	p5@SOD2	p6@SOD2	p7@SOD2	p9@SOD2	p10@SOD2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	117.27	14.42	19.29	0.78	5.26	2.53	0.00	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	120.58	15.17	18.61	0.61	6.27	2.23	0.00	0.61	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	110.15	14.66	13.89	0.19	5.02	2.89	0.19	0.39	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	172.77	17.67	12.47	0.83	3.74	1.66	0.42	0.21	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	188.52	18.00	16.20	1.57	4.95	1.80	0.22	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	177.14	17.83	12.79	0.97	3.88	2.13	0.19	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	264.95	22.01	18.74	1.53	3.05	5.66	0.00	0.44	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	224.78	18.41	11.87	2.66	4.84	2.66	0.73	0.73	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	240.65	21.59	14.32	1.07	5.56	3.63	0.85	1.07	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	383.13	26.66	14.49	1.74	6.96	1.16	0.58	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	338.34	31.13	10.51	1.62	2.43	1.21	0.00	0.40	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	358.99	32.93	13.82	1.22	7.32	1.22	0.00	1.22	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	148.14	11.77	7.74	1.29	2.10	6.29	0.32	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	117.87	7.82	5.71	0.75	2.56	4.21	0.45	0.15	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	148.42	12.73	7.68	0.88	1.54	3.95	0.00	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	140.58	10.81	6.54	1.51	1.76	3.02	0.25	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	139.13	12.23	8.30	0.66	1.09	5.02	0.22	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	132.87	10.97	7.17	1.27	1.27	2.95	0.84	1.69	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	302.83	14.93	6.93	0.53	3.73	3.20	0.53	0.53	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	294.26	17.30	7.82	1.81	2.11	3.91	0.45	0.45	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	360.59	14.03	6.95	3.07	1.87	2.14	0.40	0.53	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	521.50	18.64	4.83	4.14	2.59	3.45	0.52	0.52	0.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	476.44	16.67	8.14	2.46	2.20	2.59	0.90	0.78	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	530.71	13.59	5.82	2.18	2.18	2.43	0.97	1.21	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	831.24	28.89	10.84	4.39	4.13	3.35	2.58	1.29	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	692.21	22.47	10.76	2.22	5.38	3.80	1.58	1.90	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	733.53	19.23	9.34	4.95	6.04	2.20	2.20	0.00	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	1337.19	36.78	9.90	7.78	4.24	2.59	3.30	2.12	3.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	1043.76	28.59	9.53	7.75	5.17	4.68	2.42	0.97	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	1271.10	33.12	9.05	7.96	5.07	3.62	2.53	1.45	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	1997.35	36.64	10.68	12.98	7.12	2.93	3.35	3.77	5.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	1897.55	37.32	10.36	11.53	7.03	2.15	3.91	1.95	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	1755.76	32.08	9.50	12.24	5.91	3.17	5.91	2.11	4.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	1722.80	35.46	7.59	13.36	6.93	2.47	6.43	2.47	5.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	2110.37	48.06	7.67	13.65	7.11	2.62	3.18	3.55	1.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	2278.02	49.82	11.31	14.75	6.90	3.64	3.07	3.26	4.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	2452.56	48.44	11.24	12.88	7.36	2.04	4.70	3.88	5.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	2511.73	48.56	10.48	18.74	9.47	1.61	4.03	4.03	3.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	3152.37	61.04	11.61	17.29	5.13	2.16	4.05	6.21	4.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	3241.08	54.25	9.84	15.60	11.52	2.88	6.24	4.56	5.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	2733.48	51.05	11.76	11.53	11.06	2.12	6.35	7.53	4.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	2565.85	50.80	8.78	18.01	8.20	3.95	6.00	3.37	6.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	4046.63	75.92	10.33	28.89	9.91	2.95	6.54	5.06	5.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	3520.15	63.11	9.79	22.90	12.24	2.80	7.52	5.94	5.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	4240.92	74.89	11.64	26.70	9.44	2.41	4.22	4.02	4.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	4434.01	77.70	10.70	33.04	12.10	2.33	8.61	6.98	5.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	4574.05	74.61	9.60	27.59	10.80	2.40	3.84	6.96	4.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	4359.58	81.07	9.84	29.81	9.84	2.68	5.66	7.15	5.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	5100.34	86.65	15.32	25.13	12.93	2.63	6.22	10.05	7.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	4718.47	83.91	10.31	34.58	11.93	2.43	6.47	8.69	6.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	4940.61	70.91	11.89	42.84	13.73	2.87	5.12	7.17	7.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	5770.61	92.95	12.23	30.24	17.79	3.11	12.45	10.45	11.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	5205.09	41.98	27.98	209.88	13.99	0.00	27.98	0.00	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	5351.62	75.94	12.07	31.94	15.26	4.26	10.65	3.90	7.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	5459.89	76.22	10.60	37.45	16.57	2.65	1.99	4.64	4.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	2437.11	54.53	2.52	71.31	4.19	2.52	38.59	1.68	27.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	2693.45	63.38	6.89	45.92	11.48	3.67	8.73	2.76	11.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	5266.76	88.16	11.67	37.60	16.21	1.30	6.48	5.19	6.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	5610.51	77.72	14.45	25.05	13.81	1.61	8.35	6.42	6.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	2955.65	76.38	3.14	41.18	15.72	2.20	8.17	2.83	7.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	3538.67	70.51	11.28	20.45	13.40	3.53	2.12	4.94	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	3142.65	64.49	7.29	18.51	7.85	2.80	2.80	1.68	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	861.43	45.38	3.98	18.31	2.39	0.80	16.72	0.80	22.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	1382.17	60.14	8.49	14.61	9.85	3.40	6.80	0.68	5.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	3446.11	87.73	13.97	21.44	6.17	2.27	4.55	3.25	2.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	1564.39	52.18	7.81	5.32	6.39	2.13	3.19	1.06	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	1196.13	16.16	0.00	16.16	16.16	0.00	48.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	1232.01	39.49	0.00	15.79	0.00	0.00	15.79	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	429.99	25.84	3.90	2.44	3.41	0.98	0.00	0.98	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	423.47	30.25	7.93	2.48	5.95	0.50	0.00	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	365.91	27.21	3.75	1.41	6.10	0.00	0.47	0.94	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	547.12	36.10	4.31	3.31	4.97	0.66	0.33	0.66	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	832.75	37.74	4.64	5.88	6.50	0.93	0.31	0.93	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	779.34	44.33	5.50	5.20	4.59	2.45	1.83	0.61	0.61
Adipocyte - breast, donor1	11376-118A8	89.17	5.39	4.12	0.48	1.58	0.63	0.32	0.00	0.48
Adipocyte - breast, donor2	11327-117E4	255.56	19.73	5.78	5.45	2.57	0.64	1.93	0.80	2.41
Adipocyte - omental, donor1	11473-119C6	463.62	13.87	7.12	3.44	5.98	0.13	1.27	2.04	1.02
Adipocyte - omental, donor2	11474-119C7	186.87	14.20	4.48	2.99	2.99	0.00	0.00	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	183.20	16.75	1.00	3.35	3.01	0.67	0.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	231.59	9.57	2.55	1.91	1.91	0.64	2.55	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	134.14	12.09	3.30	1.10	2.20	1.10	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	229.88	18.97	4.97	2.26	5.42	0.45	1.81	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	311.75	40.49	7.47	3.13	4.52	0.70	1.91	0.70	0.87
Adipocyte differentiation, day04, donor1	13019-139D4	4849.21	186.38	9.78	17.21	15.84	1.96	11.54	12.32	3.32
Adipocyte differentiation, day04, donor2	13022-139D7	4904.36	108.61	10.04	26.00	22.13	1.03	12.10	15.96	1.03
Adipocyte differentiation, day04, donor3	13025-139E1	4021.85	96.18	8.36	22.30	26.48	2.23	12.54	10.59	3.62
Adipocyte differentiation, day04, donor4	13028-139E4	5301.46	158.12	8.82	25.28	27.63	1.76	14.70	10.58	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	840.93	77.86	10.46	3.78	4.99	0.56	1.69	1.37	0.48
Adipocyte differentiation, day08, donor2	13023-139D8	3576.12	103.28	7.42	26.14	14.85	0.32	18.40	5.16	2.90
Adipocyte differentiation, day08, donor3	13026-139E2	1798.44	92.77	8.53	36.26	12.26	0.53	5.87	4.27	1.60
Adipocyte differentiation, day08, donor4	13029-139E5	1556.91	61.76	9.46	11.69	8.90	0.00	6.12	3.34	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	546.07	44.08	7.07	7.07	2.08	0.83	3.33	1.66	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	2869.82	94.69	9.04	14.07	11.80	1.00	10.30	4.77	1.76
Adipocyte differentiation, day12, donor3	13027-139E3	1335.49	56.29	7.53	14.40	10.80	0.33	4.58	3.60	1.31
Adipocyte differentiation, day12, donor4	13030-139E6	544.39	31.06	3.35	2.13	3.04	0.30	3.35	0.91	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	17.02	4.64	3.76	0.22	0.88	1.77	0.00	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	3.94	0.72	2.51	0.00	0.36	0.72	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	11.98	3.59	7.19	0.00	1.20	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	1.44	2.70	4.50	0.00	1.08	1.44	0.18	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	1.67	3.35	1.67	0.00	1.67	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	2.67	2.26	2.88	0.21	2.26	1.85	0.00	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	243.27	24.14	6.64	1.37	3.20	1.37	1.72	0.23	0.46
Anulus Pulposus Cell, donor2	11463-119B5	180.99	25.96	3.92	1.71	3.92	3.43	0.98	0.24	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	1446.28	26.06	5.84	20.22	4.04	1.35	15.28	0.90	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	1554.22	28.22	5.21	13.02	6.08	1.30	19.10	2.60	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	1921.94	27.82	6.42	25.68	6.42	2.14	19.26	2.14	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	1685.02	35.27	4.18	24.51	7.77	0.90	14.65	1.79	3.29
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	1310.18	29.09	3.79	29.09	6.32	0.00	13.91	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	1470.64	29.70	1.98	12.54	5.94	0.00	13.86	1.32	5.28
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	1449.64	29.24	4.22	13.65	7.15	0.97	12.35	0.32	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	1440.79	31.55	2.91	12.14	4.37	0.97	16.50	1.46	1.94
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	1490.04	36.82	4.16	20.19	2.97	0.59	20.19	2.97	4.16
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	1372.09	25.99	5.27	20.34	6.40	1.13	16.57	2.64	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	1632.76	33.38	5.81	13.06	6.53	0.00	15.24	1.45	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	1346.56	30.09	7.52	13.79	6.27	0.00	21.31	0.00	3.76
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	2083.42	43.49	4.28	3.95	5.60	1.65	2.31	3.62	1.32
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	1315.67	30.03	1.36	12.28	4.09	0.00	13.65	0.00	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	1855.64	39.66	7.24	5.88	6.48	0.90	10.10	2.71	1.51
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	1539.32	28.40	6.97	16.61	4.82	1.07	15.00	1.61	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	1435.91	30.61	7.18	13.60	4.72	0.38	12.85	2.08	1.89
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	1756.07	32.61	6.15	14.43	8.02	1.07	16.30	1.87	4.01
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	1382.22	39.02	4.88	14.63	5.85	0.00	15.61	2.93	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	1251.24	30.68	2.49	10.62	6.14	1.00	12.94	2.32	1.99
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	1368.82	27.62	6.00	13.21	3.60	0.00	21.61	1.20	3.60
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	1122.23	21.24	10.62	7.08	10.62	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	1733.82	34.48	4.63	11.84	7.89	0.69	14.92	2.57	4.12
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	1514.38	29.36	4.19	8.39	0.00	4.19	8.39	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	1184.44	19.90	4.85	10.19	6.80	1.46	7.28	0.97	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	1178.20	29.60	6.07	10.62	4.93	0.38	5.69	2.28	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	1299.79	24.23	8.48	14.54	2.42	0.00	12.11	0.00	3.63
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	1144.63	26.79	2.28	12.54	6.27	0.57	9.69	0.00	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	1027.83	24.37	3.85	8.34	5.13	0.86	8.34	1.50	1.92
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	1130.69	22.20	5.16	9.03	5.16	0.77	10.58	1.81	2.06
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	1194.13	27.68	6.10	12.20	8.91	1.41	14.08	0.94	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	1427.36	30.87	5.14	7.40	5.79	0.32	15.76	2.25	2.25
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	1439.75	18.55	1.43	9.99	5.71	1.43	14.27	0.71	2.85
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	1241.27	25.74	3.51	11.70	4.68	1.17	14.04	1.17	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	1443.94	31.31	3.91	10.54	4.82	0.60	15.35	2.71	3.91
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	1388.76	24.95	2.38	16.63	4.75	1.19	17.82	4.75	7.13
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	1353.79	26.45	4.58	22.89	4.58	0.51	11.19	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	1462.16	33.62	4.58	11.72	5.35	1.27	15.03	1.27	3.57
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	1455.63	26.69	5.08	12.07	1.27	1.27	16.52	0.64	4.45
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	1351.99	26.76	8.20	12.95	6.47	2.16	10.36	3.02	2.59
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	1262.07	27.31	5.29	8.89	3.81	1.06	13.34	1.48	1.69
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	1610.85	28.13	2.61	8.12	3.48	0.58	20.59	4.06	6.96
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	1394.43	37.79	3.78	14.17	3.78	0.94	14.17	1.89	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	1336.70	29.50	6.27	9.32	4.58	1.02	11.53	1.86	4.07
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	1813.71	23.16	2.32	16.21	2.32	4.63	30.11	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	2032.29	46.48	2.11	16.90	6.34	2.11	8.45	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	2179.07	40.31	4.93	18.65	6.43	1.29	22.51	2.79	4.72
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	2620.85	34.29	4.21	22.86	9.02	4.21	20.46	3.61	4.81
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	2084.87	32.07	5.10	28.43	7.29	0.73	13.12	0.73	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	2264.79	44.60	3.91	24.37	7.36	0.46	14.48	3.22	2.07
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2787.48	30.60	5.10	48.46	5.10	0.00	20.40	0.00	10.20
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	3889.73	54.91	7.63	8.39	9.15	1.27	22.63	5.85	6.86
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	2968.60	50.99	4.95	21.26	10.12	0.62	21.88	3.10	5.99
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	2786.44	41.62	7.34	24.48	5.81	1.22	25.70	3.67	7.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	2657.75	36.33	2.39	39.20	5.74	2.39	18.16	1.43	2.87
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	2725.41	47.67	6.65	19.73	7.32	0.67	25.94	4.43	5.77
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	2825.78	39.67	7.63	32.04	9.15	1.53	36.62	4.58	10.68
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	2818.18	37.11	4.43	21.60	7.20	1.11	31.57	3.32	3.88
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	2771.60	45.54	5.83	20.92	9.53	0.79	26.74	3.44	7.41
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	2973.73	50.88	5.45	18.17	5.82	1.45	28.35	5.82	7.27
Astrocyte - cerebellum, donor1	11500-119F6	6.26	5.04	6.26	0.25	1.72	3.56	0.25	0.25	0.00
Astrocyte - cerebellum, donor2	11580-120F5	3.42	3.77	5.13	0.00	1.88	2.40	0.00	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	6.71	2.31	5.24	0.42	1.47	1.89	0.42	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	51.59	11.50	12.20	0.00	1.39	3.49	1.39	0.35	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	31.38	18.28	10.52	1.78	4.04	4.69	1.13	0.49	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	52.50	17.30	11.19	0.60	2.39	4.47	0.75	0.30	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	5.62	14.91	3.78	0.23	1.95	4.13	0.11	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	8.27	14.41	3.51	0.13	2.38	3.51	0.00	0.13	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	9.67	14.91	3.64	0.34	1.14	4.32	0.11	0.23	0.00
Basophils, donor1	12241-129G9	494.56	79.51	2.88	2.35	8.11	8.11	1.05	0.78	0.52
Basophils, donor2	12242-129H1	714.01	100.66	1.44	1.80	5.77	6.13	3.25	0.00	0.00
Basophils, donor3	12243-129H2	588.14	77.17	4.56	1.47	7.06	2.35	0.59	1.32	0.88
Bronchial Epithelial Cell, donor1	11511-119G8	14.66	1.94	2.16	0.00	2.59	0.65	0.22	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	9.14	0.46	1.83	0.00	1.37	1.37	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	43.04	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	15.06	0.63	2.51	0.00	0.00	1.26	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	14.76	1.87	1.87	0.21	0.21	1.25	0.00	0.00	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	13.59	2.30	1.61	0.46	0.69	0.69	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	20.15	3.78	1.08	0.72	2.70	0.72	0.36	0.36	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	36.89	17.00	6.39	0.10	1.13	6.60	0.00	0.00	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	40.76	22.82	3.73	0.47	0.47	5.82	0.70	0.00	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	146.46	43.49	11.83	0.32	5.44	14.39	0.64	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	134.45	72.39	10.34	0.00	10.34	31.03	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	4171.44	280.65	18.60	8.45	18.60	6.76	11.83	3.94	3.38
CD14+ Monocytes, donor2	11305-117B9	4121.63	300.67	18.75	31.00	19.12	6.31	16.33	6.68	9.47
CD14+ Monocytes, donor3	11381-118B4	3110.39	190.56	17.34	16.90	15.81	5.71	13.39	4.39	9.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	427.11	78.12	12.74	3.40	2.26	2.55	1.98	0.57	1.13
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	511.75	79.23	20.47	4.17	3.03	4.17	1.52	2.27	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	561.49	100.92	7.89	4.93	5.26	0.33	1.31	0.99	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	2100.59	204.39	10.55	29.49	10.99	2.75	4.05	2.89	2.89
CD14+ monocytes - mock treated, donor2	11873-125C1	1461.34	123.41	4.22	15.69	7.24	0.60	0.60	1.51	2.72
CD14+ monocytes - mock treated, donor3	11883-125D2	1491.48	127.92	7.58	12.56	10.66	3.32	1.66	2.84	1.90
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	9279.54	332.12	15.07	93.58	19.08	4.52	26.45	7.37	12.22
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	6517.74	216.39	8.83	59.07	14.63	2.48	8.28	4.42	12.14
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	8362.14	294.29	14.63	70.16	22.56	7.69	12.89	7.93	8.93
CD14+ monocytes - treated with BCG, donor1	11860-125A6	13418.42	393.36	10.18	116.11	19.97	4.31	39.94	12.14	19.58
CD14+ monocytes - treated with BCG, donor2	11870-125B7	8390.19	269.03	8.37	75.49	14.42	2.49	16.91	5.16	8.90
CD14+ monocytes - treated with BCG, donor3	11880-125C8	11200.99	434.17	15.45	79.00	23.07	9.79	16.10	11.10	8.71
CD14+ monocytes - treated with Candida, donor1	11868-125B5	16879.83	374.60	17.09	146.10	22.71	11.47	51.98	17.09	22.94
CD14+ monocytes - treated with Candida, donor2	11878-125C6	13463.13	342.16	16.37	177.42	13.73	14.26	22.71	10.56	21.12
CD14+ monocytes - treated with Candida, donor3	11888-125D7	15980.30	366.09	32.17	184.15	28.84	15.53	23.30	25.52	14.42
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	5068.01	273.85	11.75	68.28	16.66	2.23	11.60	4.46	10.71
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	3819.14	196.75	7.98	42.70	8.58	3.59	4.59	2.99	2.79
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	5876.42	296.68	14.16	37.48	17.49	4.37	10.62	5.62	5.41
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	20435.98	508.59	13.27	216.43	32.26	4.80	48.96	14.41	23.11
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	10837.21	294.29	9.50	87.31	11.31	4.75	11.99	9.95	9.95
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	16594.24	339.57	15.28	183.75	22.26	8.29	34.92	13.53	26.19
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	6205.06	347.00	10.22	74.24	12.91	2.42	12.91	5.38	2.96
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	5527.25	292.92	8.37	63.68	11.69	1.40	10.47	3.31	10.64
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	5871.71	350.12	15.15	60.18	19.78	1.68	8.42	5.05	10.52
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	26991.17	638.76	15.62	259.40	33.07	3.49	57.87	18.00	30.68
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	22145.53	458.30	13.39	162.39	29.94	2.11	28.89	18.67	16.56
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	27745.43	602.81	21.94	239.54	48.26	3.07	30.71	36.41	35.10
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	6545.65	253.37	10.64	73.06	12.03	6.10	26.85	4.53	10.11
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	5534.64	233.41	6.69	60.58	10.78	2.60	21.19	4.83	15.98
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	6680.95	333.89	19.40	48.93	16.81	9.92	12.29	7.98	4.10
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	26200.25	642.49	14.33	260.84	33.58	1.64	57.33	20.06	33.99
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	16663.56	451.08	15.53	82.75	19.24	2.32	14.37	9.27	7.65
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	23038.89	662.34	18.56	134.56	30.39	3.94	33.17	19.95	17.86
CD14+CD16+ Monocytes, donor1	11789-124B7	156.93	41.41	7.41	1.09	2.62	3.49	0.44	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	323.39	65.14	8.32	1.85	4.39	2.77	0.69	0.69	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	215.53	54.59	7.15	1.08	2.60	2.82	0.22	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	345.39	89.38	9.34	1.40	4.67	4.05	0.31	0.00	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	449.36	81.73	7.68	1.75	4.54	2.45	1.05	0.87	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	378.60	103.23	7.36	4.91	2.90	2.23	0.00	0.89	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	282.99	74.26	7.14	0.26	5.10	2.04	0.77	0.26	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	288.73	74.87	5.71	1.98	2.85	1.98	1.32	0.22	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	304.66	74.95	6.74	2.32	5.68	2.74	2.11	1.05	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	12.19	10.16	10.16	0.00	0.00	10.16	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	62.37	18.98	8.14	0.00	1.36	18.31	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	24.85	11.39	11.39	1.04	1.04	20.71	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	110.34	34.11	11.19	2.13	4.26	11.19	0.00	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	17.69	15.55	7.50	0.00	1.61	17.69	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	47.73	28.08	7.72	0.00	1.40	16.85	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	65.10	23.53	7.84	0.78	2.35	10.98	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	30.32	13.18	9.23	0.00	0.00	21.09	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	77.26	28.77	3.29	0.00	4.11	4.93	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	185.71	23.94	2.90	1.45	2.18	3.63	2.18	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	93.90	16.15	4.04	2.52	0.00	4.04	0.50	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	51.72	37.58	4.44	1.21	4.44	5.66	0.81	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	47.54	31.16	4.79	0.80	5.99	3.60	0.80	1.20	0.00
CD34+ Progenitors, donor1	11545-120B6	257.04	73.30	3.01	0.00	0.00	10.04	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	2334.87	211.80	7.30	6.74	4.49	7.87	1.69	1.69	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	74.40	34.19	10.90	0.38	2.25	9.39	0.38	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	80.05	43.97	11.95	0.23	3.38	6.09	0.23	0.23	0.68
CD4+ T Cells, donor1	11225-116C1	126.40	34.28	2.14	0.36	1.43	11.78	0.36	0.71	0.36
CD4+ T Cells, donor2	11306-117C1	120.64	55.11	1.22	3.06	3.06	9.19	2.45	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	200.99	53.07	1.52	2.44	3.96	8.23	1.52	0.30	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	12.76	17.36	6.13	0.51	0.77	8.68	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	19.09	16.40	3.59	0.22	0.90	11.68	0.45	0.22	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	10.06	13.22	6.04	0.86	0.57	10.06	0.29	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	70.64	42.67	4.74	0.47	0.95	17.07	0.47	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	66.72	38.63	2.81	0.70	2.81	24.58	1.40	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	39.55	26.37	3.30	6.59	3.30	32.96	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	9.25	13.01	3.03	0.58	0.58	5.35	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	13.39	12.71	3.56	0.68	0.34	6.10	0.34	0.17	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	11.61	11.28	4.03	0.81	0.81	7.09	0.32	0.00	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	81.14	30.48	4.48	0.45	2.69	8.97	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	55.90	33.19	1.75	0.00	1.40	9.78	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	45.76	21.12	2.20	0.44	1.32	14.52	0.88	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	12.23	14.76	5.90	0.84	1.26	3.79	0.00	0.84	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	8.52	7.06	6.65	0.21	0.62	5.40	0.21	0.00	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	10.02	9.69	7.68	1.34	0.67	5.01	0.33	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	45.14	30.73	4.62	1.36	1.63	17.40	0.00	0.27	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	44.48	35.37	3.75	0.54	1.07	17.15	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	32.28	23.31	8.97	0.00	1.79	17.93	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	15.02	16.69	7.05	0.19	0.56	7.97	0.19	0.00	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	5.85	13.43	6.50	0.65	1.08	5.85	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	9.04	9.88	5.67	0.21	0.21	4.83	0.21	0.00	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	93.03	38.93	4.55	0.51	1.01	15.67	0.51	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	103.98	44.19	5.63	0.87	3.47	15.60	0.43	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	65.37	37.04	3.49	1.74	0.87	17.87	0.44	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	48.50	23.75	5.94	0.00	1.48	19.30	1.48	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	12.92	10.16	12.00	0.92	0.00	27.70	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	19.54	25.12	4.19	0.00	1.40	15.35	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	79.20	29.91	7.75	1.11	1.94	15.51	0.00	0.00	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	16.69	25.28	6.13	0.00	0.98	19.88	0.25	0.25	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	161.70	40.04	7.70	1.54	1.54	27.72	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	137.88	45.12	4.66	0.36	3.58	11.46	1.07	0.00	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	62.32	40.16	6.92	0.00	1.38	22.16	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	86.76	20.95	1.31	0.65	1.31	11.79	0.33	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	73.21	25.15	3.75	2.25	2.25	10.51	0.75	0.38	1.13
CD8+ T Cells, donor3	11383-118B6	74.74	23.73	2.78	1.26	2.02	9.34	0.76	0.00	0.76
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	23.17	8.49	4.82	0.00	0.92	1.84	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	25.40	8.15	4.31	0.24	0.24	1.20	0.00	0.00	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	27.36	4.65	4.10	0.27	0.82	1.92	0.55	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	32.12	7.21	4.20	0.00	0.00	1.20	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	41.28	9.12	5.52	0.00	0.72	1.68	0.24	0.48	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	45.02	7.73	4.32	0.23	0.23	1.82	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	32.81	6.52	4.13	0.00	0.22	1.96	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	31.85	10.53	5.53	0.26	1.32	1.32	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	25.33	6.33	4.92	0.00	0.23	1.64	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	37.13	9.06	4.53	0.30	0.30	3.32	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	35.44	6.39	7.26	0.00	0.29	1.45	0.00	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	23.98	9.06	3.20	0.00	1.07	1.87	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	186.92	10.94	4.38	0.00	1.31	2.19	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	202.67	14.57	7.29	0.00	0.91	1.37	0.46	0.00	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	220.03	18.65	5.97	1.49	0.75	3.73	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	58.71	10.80	4.32	0.00	0.36	2.16	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	50.06	8.92	6.33	0.00	0.29	1.44	0.29	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	50.44	10.13	4.24	0.00	0.94	1.89	0.24	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	31.06	8.56	3.17	0.00	0.32	1.27	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	23.68	12.30	4.00	0.62	0.62	1.23	0.00	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	25.97	9.30	2.24	0.64	0.00	2.24	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	28.30	6.12	5.35	0.00	0.38	1.91	0.38	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	37.83	7.49	3.94	0.00	1.97	1.18	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	32.53	4.54	5.29	0.00	0.76	0.76	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	313.96	13.65	7.23	0.00	0.00	8.83	0.80	1.61	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	311.95	17.49	11.19	0.00	0.70	7.69	0.00	1.40	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	239.42	18.03	11.02	1.00	0.00	9.02	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	780.44	21.93	10.97	0.00	14.62	0.00	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	124.02	11.36	4.94	0.99	3.46	0.99	0.49	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	76.71	10.63	2.32	0.21	2.42	0.32	0.42	0.00	0.11
Chondrocyte - de diff, donor1	11261-116G1	194.48	18.37	4.85	0.35	3.81	0.00	0.69	1.04	0.00
Chondrocyte - de diff, donor2	11338-117F6	194.04	16.35	3.20	2.49	1.42	1.07	0.71	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	679.26	35.50	6.60	4.32	6.14	0.34	5.23	2.16	2.62
Chondrocyte - re diff, donor2	11339-117F7	814.68	25.07	5.37	4.48	0.00	2.69	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	1969.85	69.15	7.28	9.71	16.98	0.81	10.51	4.85	6.07
Ciliary Epithelial Cells, donor1	11242-116D9	16.30	9.52	7.69	0.23	3.33	5.39	0.23	0.34	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	9.19	3.42	7.27	0.21	2.14	2.99	0.00	0.43	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	17.79	5.31	7.52	0.62	2.04	1.95	0.27	0.00	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	236.22	39.16	7.70	1.74	6.51	2.66	0.73	1.10	0.18
Corneal Epithelial Cells, donor1	11526-119I5	19.10	3.29	1.10	0.00	0.66	0.66	0.22	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	13.65	3.41	2.28	0.00	2.28	1.14	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	18.15	3.07	2.30	0.00	2.56	1.53	0.00	0.51	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	71.32	12.38	6.44	0.17	0.83	0.66	0.50	0.00	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	64.66	16.09	10.09	0.32	1.89	1.58	1.26	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	55.21	34.51	3.45	3.45	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	116.30	17.49	4.97	1.84	0.97	1.19	1.30	0.11	0.65
Dendritic Cells - plasmacytoid, donor1	11228-116C4	294.49	32.46	5.47	0.34	3.42	7.17	1.37	0.34	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	146.90	41.78	7.83	1.31	0.00	7.18	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	101.63	23.23	5.32	0.48	1.45	6.29	0.97	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	18.51	5.00	2.84	0.50	1.33	0.83	0.50	0.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	17.02	4.69	4.69	0.00	2.93	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	18.66	5.94	3.96	0.28	1.70	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	27.52	4.33	1.97	0.39	0.39	1.18	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	59.05	6.11	3.20	0.00	1.75	0.29	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	24.00	6.35	1.65	0.71	1.18	0.24	0.00	0.00	0.47
Endothelial Cells - Artery, donor3	11413-118E9	29.28	6.49	4.38	0.35	0.70	0.70	0.18	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	45.66	7.09	9.09	0.00	2.66	0.89	0.22	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	253.45	11.26	5.48	0.91	3.04	2.74	0.61	1.83	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	220.73	23.12	5.92	0.56	3.66	1.41	0.85	0.56	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	441.84	18.42	2.38	2.67	1.78	1.78	0.89	1.49	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	598.76	14.58	2.60	3.12	4.17	0.52	1.04	0.52	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	271.81	12.34	3.97	2.41	2.69	0.43	0.85	0.43	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	145.24	16.81	4.00	0.80	1.60	0.80	0.40	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	28.83	5.24	3.14	0.00	0.52	0.00	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	20.38	11.68	4.72	0.25	1.49	1.99	0.12	0.25	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	26.72	7.17	3.69	0.00	0.87	1.09	0.22	0.22	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	20.64	7.21	7.21	0.00	1.22	0.73	0.00	0.00	0.00
Endothelial Cells - Vein, donor1	11267-116G7	6.83	2.28	6.83	0.00	3.41	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	5.59	1.40	4.19	0.70	0.00	1.40	0.00	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	17.58	4.87	3.45	0.47	1.73	0.79	0.00	0.16	0.00
Eosinophils, donor1	12244-129H3	1082.53	304.94	0.00	30.49	45.74	30.49	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	18590.21	3275.77	21.45	70.96	656.80	42.91	24.75	82.51	1.65
Eosinophils, donor3	12246-129H5	31537.84	3777.26	7.13	64.20	656.30	42.80	32.10	103.44	7.13
Esophageal Epithelial Cells, donor1	11507-119G4	23.46	2.20	1.95	0.24	1.71	1.47	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	2.08	0.00	0.00	2.08	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	292.84	32.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	71.02	12.73	4.52	1.23	4.11	0.82	0.82	0.00	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	1275.65	24.63	4.71	32.85	6.02	0.00	1.31	2.52	0.77
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	82.88	7.91	4.66	0.54	2.60	0.65	0.11	0.33	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	82.47	11.89	6.06	0.97	2.55	0.97	0.73	0.24	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	1565.74	36.30	8.60	3.68	5.32	1.36	1.64	1.77	1.50
Fibroblast - Aortic Adventitial, donor2	11326-117E3	1675.06	47.67	6.64	16.98	12.23	0.74	7.38	5.06	9.60
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	72.46	5.01	7.90	0.79	2.63	2.11	0.26	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	123.58	10.96	7.64	1.00	1.99	0.33	0.00	0.00	1.00
Fibroblast - Cardiac, donor1	11268-116G8	113.86	9.98	3.18	1.36	1.36	1.36	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	302.42	29.56	3.03	0.76	5.31	0.00	0.00	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	209.92	13.88	3.63	1.89	3.47	0.79	1.26	0.95	0.63
Fibroblast - Cardiac, donor4	11452-119A3	53.95	10.61	9.40	0.00	2.73	0.61	0.00	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	663.71	41.50	5.20	7.36	5.08	1.78	3.68	2.41	1.65
Fibroblast - Cardiac, donor6	11460-119B2	70.79	6.97	4.85	1.21	2.12	0.61	0.45	0.30	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	8.84	6.16	5.90	0.27	2.01	1.61	0.27	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	8.63	4.31	9.06	0.00	3.88	0.86	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	29.30	8.79	4.39	1.46	0.00	1.46	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	37.82	4.84	6.92	0.23	0.69	3.69	0.00	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	156.04	21.54	12.21	0.68	3.90	0.68	0.00	1.02	0.00
Fibroblast - Dermal, donor1	11269-116G9	264.36	18.55	7.28	0.94	3.52	0.70	1.41	1.17	0.00
Fibroblast - Dermal, donor2	11346-117G5	49.05	7.08	5.66	0.47	2.83	2.36	0.00	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	341.14	22.36	9.43	3.02	4.84	0.24	2.06	0.73	0.97
Fibroblast - Dermal, donor4	11450-119A1	49.06	11.42	6.10	1.58	1.47	2.26	0.45	0.00	0.11
Fibroblast - Dermal, donor5	11454-119A5	36.46	8.90	4.54	0.70	1.40	2.79	0.00	0.00	0.17
Fibroblast - Dermal, donor6	11458-119A9	26.48	11.86	5.52	0.49	1.14	2.44	0.00	0.16	0.00
Fibroblast - Gingival, donor1	11237-116D4	32.07	9.79	6.87	0.00	1.04	3.12	0.21	0.21	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	31.18	9.17	6.81	0.26	1.05	2.10	0.52	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	18.05	10.02	8.57	0.26	1.98	3.82	0.40	0.13	0.79
Fibroblast - Gingival, donor3	11394-118C8	119.60	18.27	5.80	0.68	2.71	2.03	0.19	0.19	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	1440.94	72.72	7.27	9.35	5.19	3.12	2.08	2.08	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	1020.04	42.64	4.41	12.69	8.46	0.53	8.81	2.29	4.05
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	74.05	15.90	5.92	0.47	1.25	2.18	0.00	0.00	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	33.67	11.90	5.27	0.54	1.49	1.76	0.68	0.14	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	15.53	4.23	2.82	0.35	2.12	1.41	0.00	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	47.24	8.63	5.26	0.29	1.90	1.61	0.44	0.00	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	118.08	13.77	6.00	0.55	2.18	0.95	0.14	0.14	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	27.75	9.98	3.95	0.55	1.76	1.10	0.33	0.33	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	54.29	19.96	6.16	1.32	2.93	1.17	0.15	0.73	0.00
Fibroblast - Lung, donor1	11270-116H1	20.39	4.08	5.44	0.00	1.36	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	13.43	8.95	4.48	0.00	4.48	2.98	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	29.12	7.60	3.59	0.84	1.69	2.11	0.42	0.00	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	26.66	3.33	5.83	0.00	0.00	1.67	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	39.16	4.20	6.99	0.00	1.40	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	80.88	4.20	4.20	0.28	1.40	0.28	0.28	0.56	0.00
Fibroblast - Mammary, donor1	11540-120B1	56.43	3.65	6.09	0.41	1.22	0.81	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	43.94	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	89.34	5.96	29.78	0.00	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	11.06	8.53	6.60	0.00	1.94	3.10	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	10.62	14.56	9.25	0.76	1.37	2.73	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	34.27	8.87	3.67	0.31	1.53	0.92	0.31	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	30.53	6.11	3.05	0.76	1.14	1.53	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	43.47	10.80	4.32	2.43	2.97	0.54	0.81	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	1557.42	63.67	6.61	11.37	9.28	0.35	6.15	1.39	2.09
Fibroblast - Pulmonary Artery, donor1	11250-116E8	49.74	7.30	6.08	0.44	1.99	0.22	0.44	0.44	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	55.27	8.94	4.06	0.61	2.84	0.81	0.00	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	66.82	10.02	4.01	0.67	2.67	1.34	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	184.24	13.84	3.56	0.40	3.56	0.79	0.40	0.40	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	10.52	3.37	6.35	0.00	2.58	0.79	0.00	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	65.54	11.90	4.44	0.53	3.55	1.07	0.18	0.18	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	113.13	13.40	5.12	0.20	3.35	0.39	0.59	0.79	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	10.23	2.71	8.42	0.30	0.90	0.60	0.00	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	80.10	14.68	7.99	0.76	4.10	0.86	0.22	0.00	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	15.94	3.54	7.09	0.25	1.27	2.02	0.00	0.25	0.00
Fibroblast - skin normal, donor1	11553-120C5	27.07	6.89	3.28	0.49	1.31	0.66	0.16	0.66	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	4.41	3.61	6.42	0.00	1.40	1.00	0.20	0.00	0.00
Fibroblast - skin normal, donor2	11561-120D4	18.59	6.83	3.11	0.10	1.00	0.90	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	17.53	4.53	8.46	0.00	2.12	2.12	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	83.92	13.92	7.70	0.66	2.65	0.50	0.66	0.50	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	37.44	18.63	8.03	0.85	2.56	1.71	0.17	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	6.90	2.63	6.57	0.00	0.99	1.64	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	11.08	8.42	4.05	0.32	1.81	1.07	0.11	0.00	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	25.64	7.59	4.22	0.00	1.69	2.87	0.17	0.17	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	13.80	3.76	0.47	0.00	1.10	0.47	0.31	0.16	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	22.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	81.05	9.59	11.33	0.87	6.97	0.87	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	163.30	11.27	2.60	1.21	1.39	1.21	0.35	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	341.18	20.82	2.60	1.04	1.56	2.34	0.78	0.26	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	220.51	12.26	2.30	1.28	2.56	1.28	0.26	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	11.48	8.42	10.72	0.77	6.89	3.06	0.77	0.77	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	17.23	10.21	4.47	1.28	4.47	7.02	1.91	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	13.69	15.69	5.13	1.43	5.99	6.56	1.71	0.00	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	4.41	8.82	8.82	1.10	3.03	15.72	1.10	0.28	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	17.81	13.93	13.47	2.97	3.88	14.16	1.37	0.00	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	12.88	10.30	5.15	0.79	4.95	5.15	0.59	0.59	1.19
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	6.34	8.99	12.16	1.06	3.44	11.37	0.79	0.26	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	22.18	21.20	14.35	2.94	3.91	16.96	0.98	0.98	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	10.17	9.73	5.75	1.33	2.21	8.40	1.77	0.00	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	6.36	10.32	4.38	0.42	4.24	4.66	0.42	0.14	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	18.23	9.85	4.93	0.37	5.66	5.91	0.37	0.74	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	8.60	8.33	7.25	0.27	3.76	2.15	0.00	1.07	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	8.05	6.69	2.23	0.37	3.96	3.47	0.12	0.25	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	5.54	7.61	2.21	0.42	4.01	2.77	0.00	0.14	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	2.64	4.68	2.24	0.61	0.61	1.42	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	5.70	5.93	3.19	0.00	4.11	4.34	0.23	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	8.84	4.24	3.61	0.37	2.99	3.86	0.00	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	3.50	4.37	1.97	0.44	4.37	1.09	0.22	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	5.61	4.43	6.80	0.89	7.98	2.95	0.00	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	6.84	6.36	4.77	0.32	7.47	4.93	0.16	0.48	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	6.03	4.92	4.47	0.22	4.69	1.79	0.00	0.22	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	5.04	5.24	5.04	0.00	4.64	6.25	0.60	0.40	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	5.77	6.79	5.26	0.17	5.43	4.58	0.00	0.34	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	8.69	7.18	5.32	0.53	3.81	2.57	0.18	0.27	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	5.51	4.47	5.10	0.62	2.81	4.37	0.10	0.31	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	2.90	2.73	3.59	0.34	3.24	3.59	0.00	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	4.32	5.75	5.64	0.55	6.53	5.31	0.00	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	10.48	7.32	4.58	0.00	4.66	3.66	0.25	0.25	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	10.62	5.51	3.06	0.61	5.10	5.10	0.61	1.02	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	4.95	7.63	6.19	0.21	7.01	3.71	0.21	0.21	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	3.57	7.38	6.34	0.35	6.69	6.46	0.35	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	11.51	9.51	6.84	0.83	4.50	3.50	0.17	0.33	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	5.07	3.31	5.95	0.22	4.85	2.87	0.22	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	15.13	9.22	6.15	0.25	7.13	4.18	0.25	0.25	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	12.16	8.10	4.70	0.97	5.19	4.54	0.49	0.49	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	7.06	8.66	5.77	0.32	6.41	4.49	0.64	0.64	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	6.25	5.12	3.70	0.76	5.02	3.03	0.00	0.38	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	9.65	6.64	5.06	0.63	3.48	3.01	0.32	0.63	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	5.17	8.82	3.65	1.22	4.87	2.13	0.30	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	8.47	6.27	4.81	0.10	5.33	3.87	0.21	0.21	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	10.10	5.49	2.63	0.22	4.17	1.54	0.44	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	6.73	6.17	3.09	0.28	4.77	2.52	0.28	0.84	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	18.15	6.11	4.72	0.28	3.61	2.69	0.09	0.09	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	9.09	8.56	3.21	1.87	3.74	2.41	0.53	0.53	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	7.19	7.34	3.67	0.15	4.28	1.38	0.31	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	5.70	6.22	4.40	0.39	2.98	1.42	0.26	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	5.96	8.40	2.71	0.27	2.98	1.36	0.00	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	4.98	5.35	6.27	0.55	5.71	1.29	0.18	0.18	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	5.04	5.48	3.95	0.22	3.73	2.41	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	1.98	5.95	1.98	0.00	4.96	0.99	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	11.61	6.07	4.88	0.66	4.09	1.32	0.26	0.00	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	22.19	3.83	3.83	0.61	4.84	1.41	0.00	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	7.62	8.90	2.80	0.25	4.07	2.54	0.00	0.00	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	4.78	13.93	3.98	0.20	2.79	4.98	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	12.17	8.47	4.78	0.77	5.08	2.31	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	7.57	18.21	5.93	0.61	6.75	4.30	0.20	0.61	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	12.20	10.95	8.45	0.31	1.25	11.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	9.04	5.65	9.61	0.28	2.54	7.63	0.28	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	11.53	9.69	5.53	0.00	1.84	6.00	0.46	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	9.90	9.90	4.95	0.00	0.00	14.85	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	11.60	11.99	7.74	1.55	1.55	9.28	0.39	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	12.84	12.84	4.81	0.00	4.81	9.63	0.00	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	6.96	5.22	10.43	1.74	0.00	3.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	8.46	6.84	6.18	0.33	2.28	7.16	0.98	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	6.59	7.00	9.47	0.00	2.47	11.53	0.41	0.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	6.66	19.99	13.33	3.33	0.00	3.33	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	10.91	9.79	8.11	0.84	3.08	7.83	0.00	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	10.13	7.19	6.86	0.33	0.33	5.23	0.33	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	5.87	7.55	11.74	0.00	3.36	5.87	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	11.45	7.00	8.59	1.91	2.54	8.91	0.64	0.00	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	8.49	8.83	5.09	0.68	2.04	8.83	0.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	14.62	14.62	8.35	0.00	0.00	8.35	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	8.59	4.58	6.87	0.00	1.72	11.45	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	5.33	4.74	5.03	0.30	1.48	7.40	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	6.78	16.94	6.78	0.00	0.00	11.86	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	15.33	7.87	11.18	1.24	2.90	13.67	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	11.97	9.21	9.90	0.46	2.07	9.21	0.23	0.46	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	0.00	5.27	5.27	5.27	10.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	10.76	6.54	5.00	0.77	1.15	9.99	0.38	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	11.41	9.45	11.08	0.00	0.98	16.30	0.33	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	10.70	8.03	10.03	0.67	3.34	9.36	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	6.55	10.40	8.09	0.77	2.31	14.25	0.39	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	14.38	10.27	13.35	0.00	2.05	3.77	0.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	4.97	2.48	7.45	0.00	0.00	9.94	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	5.66	15.10	6.61	0.94	3.30	17.46	0.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	6.64	11.47	7.24	2.41	2.41	14.48	1.21	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	10.68	11.19	8.65	3.56	3.56	11.70	0.00	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	10.37	13.16	9.57	1.20	1.99	17.55	0.80	0.40	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	14.80	11.84	7.40	0.99	1.97	12.83	0.49	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	25.97	7.08	8.26	0.00	1.18	11.80	2.36	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	13.42	12.25	7.58	0.58	4.08	13.42	0.58	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	15.36	14.04	4.83	1.32	1.32	11.85	0.00	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	12.72	16.11	5.93	0.00	1.70	8.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	19.70	12.54	7.76	0.60	1.79	8.95	1.79	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	12.13	7.76	10.68	0.49	0.97	6.31	0.00	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	2295.16	51.36	5.71	11.41	4.57	0.00	2.28	4.57	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	230.78	10.81	9.98	4.16	4.57	0.83	0.42	1.25	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	30.36	4.50	4.50	1.12	3.37	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	1655.26	34.57	5.71	11.42	13.00	0.63	6.66	2.85	2.54
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	896.47	32.17	4.60	6.68	4.60	0.42	7.10	1.25	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	76.82	11.49	3.83	1.16	0.58	1.04	0.46	0.23	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	87.78	13.00	2.70	0.51	1.69	0.68	0.51	0.17	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	79.40	8.19	2.28	0.68	2.05	1.14	0.23	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	104.06	10.60	3.06	1.09	1.86	1.09	0.33	0.22	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	102.73	7.74	1.72	1.50	2.15	0.86	0.21	0.43	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	81.16	8.18	2.15	0.65	1.29	1.72	0.22	0.65	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	127.53	12.45	1.87	2.37	1.37	1.49	1.00	0.25	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	103.10	10.12	1.89	1.20	1.89	0.69	0.17	0.17	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	122.06	9.93	3.20	1.28	1.92	1.60	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	13.99	6.16	8.39	0.56	1.68	1.68	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	18.18	2.16	3.46	0.00	1.73	0.00	0.00	0.87	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	55.52	10.58	10.58	2.64	0.00	0.00	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	29.98	5.64	5.29	0.00	0.71	2.12	0.00	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	13.08	2.18	1.45	0.00	0.73	0.73	0.73	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	63.47	8.04	4.90	1.22	2.62	1.75	0.52	0.35	0.52
Hepatocyte, donor1	11523-119I2	2625.80	110.16	20.58	27.84	12.11	2.42	19.37	0.00	4.84
Hepatocyte, donor2	11603-120I1	4168.22	193.92	7.54	52.79	23.70	2.15	30.17	6.46	2.15
Hepatocyte, donor3	11684-122I1	1104.37	52.15	15.95	26.38	11.04	4.91	9.20	4.91	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	59.39	24.80	15.66	0.65	2.61	13.71	0.00	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	39.50	22.02	9.26	0.70	5.59	3.85	0.52	0.17	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	8.92	4.67	1.65	0.14	1.65	0.96	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	15.92	28.66	3.18	0.00	0.00	6.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	6.68	0.00	13.35	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	19.38	19.38	5.54	1.38	1.38	1.38	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	5.01	2.50	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	11.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	17.94	12.81	0.00	0.00	5.13	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	18.28	27.42	0.00	0.00	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	25.99	17.87	3.25	1.62	1.62	0.00	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	16.67	5.00	6.67	1.67	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	14.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	19.85	25.15	3.97	2.65	1.32	3.97	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	14.41	11.09	2.22	0.00	0.00	0.00	0.00	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	5.24	10.48	0.00	15.71	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	11.34	14.49	5.67	0.63	0.63	1.26	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	21.65	12.37	1.55	0.00	0.00	1.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	13.57	10.98	4.52	1.94	1.29	2.58	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	25.76	12.88	6.44	1.61	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	11.95	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	27.71	18.74	8.96	0.81	1.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	21.83	16.37	1.68	0.00	0.42	1.68	0.00	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	14.37	0.00	0.00	0.00	14.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	16.07	20.90	4.02	0.80	1.61	4.02	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	16.62	13.85	3.69	0.00	1.85	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	15.08	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	16.99	18.41	5.19	0.94	1.89	0.94	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	21.77	16.33	4.53	0.91	2.72	0.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	23.67	27.98	6.46	0.00	4.30	2.15	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	43.20	13.98	6.35	0.00	2.54	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	16.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	22.32	18.49	5.74	1.28	0.00	1.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	38.28	20.05	3.65	1.82	5.47	5.47	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	25.71	18.57	4.28	0.71	0.71	2.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	29.86	23.23	3.32	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	20.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	19.14	16.05	5.56	1.54	1.23	1.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	36.88	17.56	5.27	0.00	0.00	3.51	0.00	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	28.29	12.57	3.14	3.14	0.00	3.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	25.73	28.51	3.48	1.39	2.78	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	11.07	11.07	4.43	0.00	0.00	4.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	16.21	3.24	0.00	0.00	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	16.57	6.98	2.62	0.00	2.62	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	13.50	13.50	2.25	0.00	0.00	4.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	6.97	3.48	10.45	0.00	0.00	10.45	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	10.67	12.80	5.33	2.13	1.07	2.13	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	15.24	9.70	4.16	0.00	4.16	2.77	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	14.25	11.40	0.00	0.00	2.85	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	23.93	12.89	3.68	0.00	1.84	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	6.05	3.03	0.00	3.03	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	6.21	6.21	0.00	6.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	11.63	11.63	4.23	0.00	1.06	2.11	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	46.27	4.98	1.14	0.33	2.61	0.49	0.24	0.24	0.16
Keratinocyte - epidermal, donor2	11349-117G8	14.06	2.34	1.17	0.00	1.17	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	7.95	4.26	2.46	0.47	2.18	1.23	0.09	0.19	0.00
Keratinocyte - oral, donor1	11251-116E9	75.38	13.28	2.27	0.57	2.50	2.04	0.57	0.23	0.23
Keratocytes, donor1	11527-119I6	27.85	8.94	8.25	0.00	1.72	1.72	0.34	0.00	0.00
Keratocytes, donor2	11607-120I5	26.95	4.69	5.86	0.00	0.00	0.00	0.00	0.00	1.17
Keratocytes, donor3	11688-122I5	185.54	22.72	3.56	1.19	4.35	0.79	0.99	0.40	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	21.98	8.79	4.40	0.00	2.20	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	8.63	5.39	5.39	0.00	4.31	1.08	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	25.03	9.80	6.00	0.12	3.00	3.81	0.23	0.00	0.23
Lens Epithelial Cells, donor3	11690-122I7	17.05	4.44	4.64	0.30	2.02	0.91	0.00	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	4185.65	91.30	8.77	19.57	9.96	1.07	7.00	7.83	1.42
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	4938.50	84.84	8.37	27.91	15.07	1.12	25.12	5.58	8.37
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	8798.23	118.06	7.56	62.65	18.89	1.73	29.59	11.18	5.67
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	4245.80	72.59	6.99	21.51	11.29	2.15	18.82	2.15	2.69
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	4262.62	70.28	8.51	22.38	7.25	0.95	17.02	3.47	5.04
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	5054.66	76.87	5.71	41.83	13.69	1.08	13.58	5.61	2.05
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	5111.02	84.95	4.92	23.80	11.08	1.23	21.75	7.80	6.98
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	3138.76	51.83	7.33	12.64	9.86	1.26	9.35	3.79	1.77
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	5602.99	92.61	5.49	42.23	12.67	1.69	14.22	7.18	3.94
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	4785.16	72.78	7.52	20.57	7.91	1.19	20.17	3.16	4.75
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	5842.50	84.53	8.34	22.68	13.96	2.13	23.46	5.43	5.82
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	4110.48	69.43	6.67	24.07	10.37	1.30	10.37	5.55	1.30
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	4739.96	79.79	6.27	25.09	6.27	1.05	19.51	4.53	5.92
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	4730.64	67.98	8.35	14.31	11.69	1.43	14.55	5.25	2.86
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	5741.69	85.16	4.53	35.71	11.54	1.65	17.72	5.49	3.57
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	5756.66	81.30	6.16	34.18	8.31	0.00	22.79	3.70	5.24
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	3900.85	57.67	7.79	15.59	7.79	0.62	10.60	4.99	4.05
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	5289.71	85.46	4.57	27.63	10.98	2.56	8.78	7.69	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	4897.50	75.70	5.92	20.08	8.56	0.33	18.10	5.92	1.97
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	4086.44	58.57	4.98	18.45	9.08	1.17	8.79	5.86	3.51
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	5221.53	76.42	3.98	35.60	10.95	1.24	9.46	5.97	2.49
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	4921.41	71.29	5.82	21.34	8.24	0.00	16.49	2.91	4.36
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	5249.66	94.25	8.62	26.12	10.50	1.89	20.20	7.81	4.31
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	6217.54	98.70	5.30	53.13	11.50	1.36	16.50	5.90	3.03
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	4635.64	65.84	8.81	18.14	10.89	1.56	11.92	6.22	4.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	5870.27	87.94	8.17	23.66	9.84	0.63	24.71	6.07	6.91
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	5439.40	89.17	3.61	35.19	14.59	2.56	15.04	6.01	2.26
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	4835.77	68.10	5.50	22.70	11.01	1.38	21.32	4.13	4.82
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	5020.55	78.65	7.15	24.08	9.22	0.75	16.56	6.21	4.33
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	4597.77	76.87	2.86	37.75	11.98	0.95	8.06	6.15	1.91
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	4538.55	63.48	5.81	16.48	9.69	0.97	20.84	7.27	3.88
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	5085.88	72.11	6.95	25.80	10.92	1.32	12.90	4.30	5.62
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	4808.98	89.33	5.33	34.19	10.04	1.73	11.89	5.08	1.24
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	6327.63	87.74	8.14	33.32	10.74	2.22	24.43	7.77	2.59
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	6010.77	90.43	6.18	21.99	10.38	1.98	16.31	9.14	4.45
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	4994.32	82.36	4.12	34.51	9.90	1.51	9.76	5.50	2.47
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	4660.54	71.08	5.47	25.73	10.29	0.96	21.87	6.43	5.47
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	7027.27	119.30	12.17	27.69	12.78	2.13	21.91	5.48	7.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	6854.56	107.63	5.32	39.89	11.62	2.24	20.02	5.74	5.88
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	4059.09	69.69	5.69	23.47	4.27	1.42	24.18	3.91	3.20
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	4132.23	62.05	8.73	18.91	5.33	2.42	5.82	4.36	2.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	4633.84	74.85	3.42	25.83	8.87	0.93	8.09	4.98	2.49
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	4308.37	51.57	6.09	24.71	7.16	0.36	17.91	3.94	5.01
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	4766.18	83.96	5.55	15.03	6.53	1.63	6.53	4.25	2.29
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4286.59	66.62	5.18	23.07	8.24	1.41	7.53	3.30	0.94
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	3681.86	71.78	5.94	13.74	7.55	2.10	5.32	5.82	1.49
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	3283.81	53.53	4.35	11.78	5.89	2.05	7.94	4.10	1.02
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	5007.92	79.06	5.67	41.47	11.93	0.90	9.25	7.16	1.79
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	4.53	2.27	11.33	0.00	0.00	4.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	3.84	2.30	13.04	0.00	0.77	1.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	1.48	1.48	15.59	0.74	2.23	2.97	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	7.62	2.96	11.85	0.42	0.00	3.39	0.00	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	4.22	1.41	11.25	0.00	2.11	3.52	0.00	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	4.67	0.93	10.27	0.00	0.93	3.74	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	4.12	3.09	9.27	0.52	0.00	2.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	3.57	1.19	8.33	0.00	0.00	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	2.71	1.13	11.08	0.23	0.23	4.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	6.40	2.62	15.41	0.29	1.45	2.91	0.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	8.55	0.90	14.41	0.45	0.45	3.60	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	3.93	1.63	12.19	0.00	1.08	3.52	0.00	0.14	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	5.65	1.03	9.76	0.51	0.00	4.62	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	2.47	2.47	9.88	0.00	1.41	2.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	6.66	2.67	12.66	0.00	1.33	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	7.64	1.53	12.73	0.51	0.00	3.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	1.87	1.33	12.01	0.00	1.07	2.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	5.48	3.21	10.96	0.57	1.89	3.02	0.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	2.45	1.84	12.88	1.23	0.00	3.68	0.00	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	11.42	4.08	13.86	0.00	1.63	2.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	8.12	1.67	10.83	0.21	1.87	2.08	0.21	0.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	7.01	3.36	17.10	0.28	1.40	3.08	0.00	0.00	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	2.06	2.06	15.46	0.00	1.03	2.06	0.00	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	5.81	3.19	12.19	0.29	0.87	2.61	0.29	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	4.48	2.69	14.65	0.00	2.09	2.99	0.00	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	4.43	2.21	13.28	0.00	0.55	3.87	0.00	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	3.53	0.71	10.25	0.71	1.41	2.12	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	6.27	3.69	16.23	1.11	1.84	3.32	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	6.91	0.00	9.21	0.00	2.30	2.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	5.37	1.54	8.44	0.38	0.77	3.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	4.53	0.00	13.59	0.00	1.70	0.57	0.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	7.38	3.28	9.85	0.00	1.64	3.28	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	5.42	1.81	15.82	0.90	2.71	3.16	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	2.87	1.44	16.52	1.44	0.72	5.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	6.72	4.48	7.47	0.00	0.00	2.99	0.75	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	6.69	1.11	10.03	0.00	1.49	3.34	0.00	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	9.48	2.15	6.89	0.00	2.15	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	6.85	0.86	6.85	0.00	0.86	2.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	4.66	1.00	15.99	0.33	0.67	3.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	7.84	1.21	13.27	0.00	1.21	2.41	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	7.82	2.13	9.95	0.00	2.13	1.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	4.81	2.06	11.69	0.69	0.00	3.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	5.90	0.54	12.88	0.54	0.00	4.83	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	5.39	1.35	12.12	0.00	0.67	4.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	5.93	0.37	11.48	0.37	1.48	3.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	3.49	3.49	4.65	0.00	4.65	6.98	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	3.17	1.06	8.46	0.00	1.06	3.17	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	6.40	0.80	12.40	0.00	0.40	3.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	10.90	3.63	19.63	0.73	1.45	0.73	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	3.83	2.30	17.63	1.53	3.07	3.83	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	3.95	1.48	12.83	0.00	0.49	3.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	5.65	1.88	15.05	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	4.53	1.51	14.08	0.00	1.51	3.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	6.76	2.70	10.81	0.00	0.90	4.06	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	5.16	0.00	15.49	0.00	0.00	8.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	7.57	0.89	13.36	0.00	0.89	3.12	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	5.47	1.17	9.38	0.39	0.39	2.35	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	5.28	1.32	11.88	0.00	0.66	3.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	6.23	1.04	8.30	1.04	2.08	3.11	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	5.25	0.88	14.44	0.44	4.38	1.31	0.44	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	6.71	1.68	11.74	0.56	1.12	3.35	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	7.07	1.32	11.48	0.00	0.44	2.65	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	5.79	2.31	13.50	0.00	0.77	0.39	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	4.05	1.01	19.24	0.51	1.01	1.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	4.81	2.40	8.17	0.48	1.44	2.88	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	7.55	0.80	16.70	0.40	1.19	2.39	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	5.47	0.00	12.76	0.00	0.61	1.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	2.77	2.08	17.29	0.00	2.77	2.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	4.18	2.66	12.16	0.38	0.76	4.56	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	7.23	2.58	13.43	0.52	1.55	3.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	6.65	0.60	12.09	0.00	0.00	3.63	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	3.80	2.54	11.41	0.63	0.95	2.22	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	10.13	1.07	16.53	0.00	0.53	5.86	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	2.30	3.45	9.19	0.00	1.15	5.17	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	3.60	2.57	14.40	0.00	0.51	4.11	0.00	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	4.24	5.66	8.49	0.00	0.71	4.95	0.00	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	5.67	1.70	13.62	0.57	0.00	5.67	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	5.82	2.50	12.48	0.83	1.66	0.83	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	4.70	3.92	9.40	0.78	0.78	5.48	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	4.18	0.84	10.86	0.00	0.00	1.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	4.18	1.39	13.94	0.46	0.93	3.72	0.00	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	7.36	2.01	12.04	0.67	1.34	4.01	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	3.21	0.00	10.16	0.00	1.07	4.28	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	5.66	0.40	10.51	0.40	1.21	2.42	0.00	0.81	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	5.51	2.75	8.26	0.00	0.92	0.92	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	2.67	0.89	12.45	0.00	1.78	0.89	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	5.70	0.57	10.26	0.57	1.14	3.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	7.67	0.00	6.90	0.77	0.77	6.90	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	3.83	0.55	8.21	0.00	0.00	4.92	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	0.45	0.45	12.03	0.45	0.00	1.78	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	7.28	2.34	9.62	0.00	1.04	6.50	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	4.64	1.33	5.97	0.00	0.00	1.99	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	4.16	2.08	14.55	0.00	0.00	4.16	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	709.50	68.15	6.15	2.28	3.65	0.68	4.10	1.14	0.46
Macrophage - monocyte derived, donor2	11313-117C8	1036.82	61.29	6.24	3.85	2.75	0.18	3.30	2.75	0.18
Macrophage - monocyte derived, donor3	11389-118C3	1463.26	76.42	6.16	12.32	5.24	0.79	6.29	2.23	1.70
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	254.36	15.40	1.06	0.00	0.00	1.06	1.06	0.53	1.06
Mallassez-derived cells, donor2	11929-125I3	20.28	5.86	1.58	0.16	1.27	0.79	0.00	0.16	0.32
Mallassez-derived cells, donor3	11930-125I4	289.65	19.46	0.83	1.67	2.22	1.95	0.69	0.42	0.14
Mammary Epithelial Cell, donor1	11273-116H4	156.54	13.75	5.58	0.30	2.09	1.20	1.20	0.50	0.80
Mammary Epithelial Cell, donor2	11350-117G9	44.30	9.84	2.61	0.29	2.61	1.16	0.00	0.29	0.29
Mammary Epithelial Cell, donor3	11422-118F9	12.47	3.99	1.50	0.00	0.50	0.75	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	66.44	27.12	12.20	0.68	0.68	3.39	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	16.87	14.17	4.00	0.65	1.30	4.22	0.00	0.00	0.11
Mast cell, donor2	11565-120D8	52.60	11.00	3.27	1.49	2.67	2.38	0.00	0.30	0.00
Mast cell, donor3	11566-120D9	45.02	18.46	4.50	1.58	2.25	2.48	0.68	0.00	0.68
Mast cell, donor4	11567-120E1	47.34	12.41	3.90	1.60	2.66	3.55	0.18	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	63.76	10.53	5.99	0.55	0.67	4.32	0.33	0.00	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	17.51	4.67	5.25	1.17	0.00	2.92	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	7.92	9.64	6.77	0.23	0.69	4.24	0.11	0.00	0.00
Mast cell, expanded, donor8	11941-126A6	19.25	13.89	7.03	0.50	1.00	2.01	0.00	0.00	0.17
Melanocyte - dark, donor1	11502-119F8	85.47	7.36	4.97	0.30	1.49	1.49	0.30	0.00	0.00
Melanocyte - dark, donor2	11582-120F7	134.28	16.96	3.81	1.73	2.77	1.04	0.00	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	72.73	26.01	9.42	0.29	5.58	0.94	0.36	0.14	0.36
Melanocyte - light, donor1	11274-116H5	18.10	4.47	2.59	0.47	2.59	0.71	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	11.60	0.68	2.73	1.36	0.68	1.36	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	71.11	9.54	2.60	0.00	2.60	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	19.89	14.16	8.12	0.94	6.66	1.15	0.52	0.31	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	24.20	15.33	7.80	0.00	3.50	1.08	1.08	0.27	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	31.61	14.20	5.62	0.80	6.43	1.07	0.54	0.80	0.54
Meningeal Cells, donor1	11493-119E8	12.16	6.08	4.59	0.00	0.99	2.98	0.00	0.00	0.00
Meningeal Cells, donor2	11573-120E7	13.20	3.08	2.20	0.00	2.64	3.96	0.00	0.44	0.00
Meningeal Cells, donor3	11654-122E7	9.86	7.01	5.30	0.16	2.36	1.87	0.00	0.08	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	33.93	8.27	8.84	0.29	1.43	1.71	0.00	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	584.87	25.26	6.44	2.52	3.32	0.20	1.51	1.21	1.11
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	89.36	7.88	9.20	0.00	1.31	0.00	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	15.70	1.31	1.31	1.31	1.31	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	88.27	13.63	3.59	0.72	2.87	0.72	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	63.32	5.29	7.84	0.85	1.91	1.48	0.00	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	52.28	6.03	10.56	0.50	0.50	1.01	0.50	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	14.06	7.03	6.15	0.00	1.10	0.88	0.22	0.66	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	5.84	5.11	7.31	0.00	0.00	1.46	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	9.21	4.50	8.59	0.41	0.82	1.02	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	222.72	9.42	6.23	0.28	3.05	0.14	0.42	1.25	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	44.98	3.35	4.46	0.00	1.49	0.37	0.00	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	127.50	11.05	3.16	0.39	2.76	0.53	0.39	0.66	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	49.56	9.79	2.97	0.00	0.89	1.48	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	21.02	2.34	4.67	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	28.82	7.04	3.84	0.00	1.28	2.56	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	108.11	16.66	3.19	0.71	2.84	0.35	1.06	0.71	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	103.20	8.44	1.88	0.63	2.50	0.00	0.63	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	201.74	12.34	4.35	0.73	3.63	1.45	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	970.01	23.34	7.16	2.92	6.10	0.53	3.18	4.51	3.18
Mesothelial Cells, donor2	12156-128G5	342.32	18.02	8.01	0.50	0.50	2.00	0.00	1.50	0.00
Mesothelial Cells, donor3	11402-118D7	611.65	22.26	2.53	3.90	4.34	0.14	3.90	1.23	3.04
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	159.34	32.41	2.70	0.00	2.70	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	427.29	41.13	3.94	3.20	2.22	0.25	2.96	0.00	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	457.29	45.35	6.48	2.65	2.06	0.00	2.65	1.18	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	276.57	17.29	3.46	0.00	0.00	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	428.97	31.92	3.10	5.58	1.86	0.00	1.55	0.31	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	471.70	42.32	5.39	2.28	2.90	0.62	2.49	0.41	1.04
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	479.42	34.74	4.63	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	966.01	51.05	4.25	7.76	3.50	1.50	4.25	0.75	1.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	768.97	46.08	3.72	0.93	3.72	0.93	0.93	2.33	1.40
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	2316.47	58.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	1319.68	49.18	5.08	11.38	1.83	1.42	9.14	1.83	2.64
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	1233.82	49.89	4.75	3.17	3.56	0.00	3.96	1.58	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	1889.88	17.10	8.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	1569.88	38.05	7.08	19.47	3.54	0.88	0.88	2.65	5.31
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	1816.86	65.73	12.16	6.84	5.70	0.76	9.88	3.80	5.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	3418.73	61.85	9.21	1.32	3.95	0.00	0.00	5.26	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	3541.60	75.76	5.73	33.74	3.61	0.64	13.58	4.46	6.79
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	1893.22	58.01	2.76	0.92	4.60	0.00	1.84	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	215.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	4225.54	87.33	4.77	33.08	7.15	0.00	24.44	6.26	4.77
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	1691.77	31.86	10.06	1.68	5.03	0.00	0.00	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	3904.17	169.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	6436.67	104.88	7.03	69.00	8.53	0.50	27.10	5.77	13.05
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	2771.20	71.54	8.56	11.41	7.37	0.24	11.65	5.23	1.19
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	7679.55	125.50	5.53	14.37	4.98	0.55	10.50	8.29	3.32
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	8291.84	113.28	8.75	60.55	9.90	0.46	27.17	9.21	11.05
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	3350.91	83.50	8.20	14.72	4.00	0.00	7.57	4.21	3.79
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	7643.97	139.21	5.71	41.99	12.43	0.41	13.45	9.58	4.48
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	6003.02	88.39	6.65	39.90	6.44	0.21	23.81	7.08	5.36
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	3859.64	90.47	4.22	9.11	10.67	0.22	8.45	6.89	2.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	6820.52	92.87	10.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	9731.36	154.41	6.79	51.03	14.46	0.00	36.58	10.07	16.65
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	3616.63	74.02	1.52	6.08	8.11	0.00	3.55	8.62	3.55
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	9990.03	127.59	3.31	13.26	13.26	0.00	4.97	18.23	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	10518.07	173.13	5.98	79.36	11.14	0.00	22.02	15.49	3.26
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	5824.31	105.28	4.41	15.00	10.00	0.29	12.35	12.65	4.12
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	10401.69	127.57	6.54	26.17	14.17	0.00	5.45	16.35	2.18
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	9849.92	150.41	3.36	74.97	12.01	1.44	50.94	9.13	14.42
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	6753.06	134.88	6.00	35.22	9.21	0.80	20.81	8.00	8.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	8044.93	116.55	2.74	8.23	17.83	0.00	28.80	4.11	8.23
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	12785.25	173.20	6.51	99.61	18.52	0.50	46.55	12.51	14.52
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	15225.14	134.74	53.89	80.84	26.95	0.00	53.89	53.89	26.95
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6686.28	83.58	2.04	4.08	16.31	0.00	0.00	6.12	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	19973.62	260.56	4.82	132.25	28.03	0.00	95.03	22.77	21.46
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	4851.66	79.46	7.73	5.52	8.83	0.00	11.04	7.73	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	9874.15	135.76	4.48	10.25	26.90	0.00	5.12	16.65	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	21051.54	260.07	7.19	127.93	19.83	0.50	72.64	19.34	19.83
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	4991.66	89.07	6.26	6.96	3.48	0.00	7.65	11.83	2.78
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	10846.05	150.27	8.84	13.26	11.05	0.00	13.26	11.05	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	16789.54	210.94	4.10	124.10	22.56	1.03	56.07	18.80	14.36
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	5715.68	81.83	5.25	15.32	15.32	0.00	7.44	11.82	2.19
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	9067.38	134.23	8.17	13.14	20.24	0.71	12.43	10.65	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	18897.67	233.42	5.33	133.82	20.20	0.56	71.82	18.24	28.62
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	6935.17	101.00	8.73	20.37	12.05	0.00	10.39	7.90	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	8038.40	97.32	7.58	4.66	13.40	0.00	10.49	11.65	1.75
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	13440.99	175.57	4.83	90.80	23.23	0.60	58.82	15.08	22.93
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	7364.03	122.71	10.43	43.83	17.11	0.42	14.19	10.43	10.85
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7861.30	79.41	7.22	0.00	21.66	0.00	14.44	14.44	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	12504.01	176.40	5.54	178.25	14.78	0.00	20.32	4.62	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	7701.30	125.78	17.64	36.99	22.76	0.57	12.52	16.50	3.41
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	8636.34	132.93	5.80	41.59	17.83	0.83	7.88	10.92	0.55
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	12060.25	157.30	3.89	93.55	21.25	1.55	45.61	13.73	20.73
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	6522.59	87.51	9.87	24.88	24.02	0.00	8.15	14.59	3.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	7144.64	83.21	2.54	8.26	17.79	0.00	3.18	17.15	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	10844.51	110.23	5.07	48.04	18.68	0.53	38.97	10.41	4.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	8870.03	171.52	8.68	45.80	20.95	1.20	19.16	13.47	5.99
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	7474.60	121.05	4.38	31.36	17.52	0.28	8.33	8.19	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	11485.91	131.23	9.87	89.82	22.61	0.96	50.33	12.74	17.52
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	7031.07	113.66	10.61	29.85	23.88	0.22	12.60	12.16	2.87
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	9006.00	105.80	4.93	19.34	21.99	1.52	1.90	9.86	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	11680.74	132.96	6.53	67.90	19.32	0.57	41.20	13.64	4.55
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	7883.66	120.44	9.59	48.18	23.84	1.23	14.75	15.49	5.90
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	7397.11	114.04	4.56	11.73	16.29	0.00	7.17	6.52	1.30
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	10248.92	143.19	5.29	69.98	17.35	0.00	35.87	15.00	5.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	7700.91	144.74	6.63	46.13	10.67	0.29	12.97	11.53	5.19
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	12345.77	270.78	6.18	47.81	28.03	0.82	11.13	14.43	4.12
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	10336.05	162.89	4.47	39.61	19.65	0.00	26.80	12.80	7.15
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	2211.16	82.87	3.77	11.30	0.00	0.00	26.37	3.77	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	777.06	64.16	5.35	5.35	5.35	1.78	5.35	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	1963.54	116.97	3.61	13.47	6.90	0.00	8.87	2.96	2.63
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	1637.89	118.87	10.52	14.73	5.26	2.10	10.52	2.10	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	1043.98	81.25	7.71	3.76	3.56	0.40	4.15	0.99	1.19
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	781.38	101.51	4.66	6.52	3.73	3.73	1.86	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	502.08	37.55	6.76	6.01	2.25	0.00	3.38	0.38	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	744.69	54.87	5.06	5.06	2.13	0.00	4.00	0.80	1.86
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	1900.32	114.12	7.46	6.90	5.77	0.00	5.20	2.26	0.68
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	802.29	47.89	4.42	6.63	5.16	0.00	5.16	0.00	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	1683.35	104.80	5.86	15.76	1.83	0.00	5.13	0.73	6.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	1678.49	110.45	12.44	46.67	7.78	1.56	18.67	0.00	4.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	2641.73	126.13	8.55	12.83	3.74	1.60	3.74	4.81	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	2020.82	108.19	3.86	15.46	3.86	0.00	15.46	0.00	7.73
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	1914.85	89.88	5.05	16.16	7.07	2.02	12.12	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	2042.42	106.25	6.32	16.44	5.06	0.00	10.54	1.69	4.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	2917.28	138.92	29.96	9.53	13.62	4.09	0.00	6.81	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	2984.42	135.42	6.99	15.89	5.72	1.27	1.27	1.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	3101.67	122.29	5.67	16.20	6.48	2.43	1.62	4.05	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	1860.86	108.75	9.06	19.64	1.51	4.53	3.02	4.53	3.02
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	8393.95	388.29	62.81	45.68	34.26	5.71	0.00	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	7594.98	316.46	58.72	65.25	13.05	13.05	9.79	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	5726.73	175.84	23.76	33.27	19.01	0.00	0.00	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	3049.42	125.49	62.75	25.10	0.00	0.00	12.55	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	12.06	3.02	5.60	0.22	1.72	0.22	0.00	0.22	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	20.38	3.66	4.70	0.52	4.18	1.05	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	18.02	3.34	4.67	0.00	0.00	1.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	12.52	2.50	3.34	0.00	0.83	0.83	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	8.18	5.89	2.85	0.00	1.14	0.76	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	30.32	4.79	9.58	0.00	0.00	0.00	0.00	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	44.20	4.08	4.76	0.68	0.00	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	12.86	0.00	1.84	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	753.78	12.97	8.79	3.35	5.44	0.42	0.00	0.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	227.09	13.25	6.97	0.46	2.09	1.63	0.23	0.46	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	399.13	14.05	7.84	1.62	4.32	0.81	0.27	1.89	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	1363.17	32.80	12.61	5.89	6.52	0.42	3.99	3.15	1.89
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	1436.38	55.67	11.13	11.13	0.00	0.00	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	2482.77	29.78	11.91	15.39	8.44	0.50	3.47	7.45	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	1432.66	38.71	6.23	7.04	8.66	0.54	2.71	2.71	1.35
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	1143.61	22.21	9.97	7.25	8.61	0.23	0.91	0.91	1.13
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	863.21	22.54	7.84	1.80	7.51	0.82	0.65	2.78	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	2311.18	55.59	9.66	22.24	14.58	0.55	10.94	6.38	2.37
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	2196.54	28.64	8.49	10.08	6.90	2.65	2.65	7.43	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	3709.89	57.63	14.41	13.21	16.21	0.60	0.00	7.80	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	949.74	30.19	3.94	5.91	7.22	0.00	5.91	0.98	2.30
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	2085.97	32.20	6.83	8.13	10.57	0.33	2.93	3.09	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	1811.80	46.04	7.23	8.64	15.52	0.71	6.53	6.70	1.41
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	2565.39	29.54	8.44	15.47	11.95	1.41	0.70	7.03	2.11
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	3541.60	60.68	16.55	7.82	15.17	0.00	2.76	8.73	2.76
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	1892.08	42.42	9.00	13.82	12.53	0.96	2.57	4.18	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	1353.34	46.56	3.45	14.49	7.59	0.34	7.59	0.34	4.83
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	452.59	20.23	0.00	0.00	2.53	2.53	0.00	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	1923.97	54.80	7.13	6.02	16.49	0.22	3.56	8.69	1.78
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	1848.95	31.75	9.74	5.50	13.13	0.00	3.81	3.81	2.96
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	2599.47	65.03	9.26	8.31	12.10	1.19	4.27	4.03	2.61
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	1580.49	42.50	12.45	8.16	9.44	0.00	0.43	4.29	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	2518.74	72.22	0.00	18.06	0.00	0.00	18.06	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	953.68	32.32	10.33	3.00	7.66	0.00	0.67	3.67	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	1661.43	42.38	8.57	1.80	9.02	0.45	4.51	7.66	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	930.50	27.78	9.13	2.78	3.57	0.40	0.40	1.59	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	5063.90	68.72	18.57	36.22	13.93	0.00	2.79	8.36	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	1199.06	49.19	8.32	5.68	9.46	1.14	1.14	2.27	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	1201.54	29.33	10.43	7.82	8.80	0.65	0.98	3.58	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	645.40	19.61	9.15	2.18	9.15	0.00	0.00	2.18	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	736.78	28.49	4.98	0.00	9.50	1.81	0.90	3.62	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	1210.86	17.64	5.29	8.82	9.70	0.00	0.00	2.65	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	3201.90	46.54	11.30	19.28	11.97	1.33	1.33	5.98	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	1527.81	34.23	7.44	7.94	8.43	0.50	0.99	4.96	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	664.97	18.38	8.80	0.77	6.89	0.38	1.15	1.53	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	610.64	30.24	12.10	2.42	7.26	2.42	0.60	0.91	1.51
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	1406.60	36.47	5.53	7.07	10.83	0.44	5.08	6.41	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	1162.86	24.40	8.81	4.07	8.81	0.68	0.68	2.03	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	1701.47	45.99	5.11	15.33	15.33	0.00	15.33	0.00	10.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	1124.25	28.05	15.85	5.49	4.27	0.61	0.61	3.05	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	484.69	19.20	6.29	0.31	5.98	0.31	0.31	3.15	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	402.53	20.28	7.26	1.21	8.17	0.00	0.61	2.72	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	1055.38	26.90	9.49	8.70	6.33	0.00	0.79	3.96	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	920.52	24.94	3.40	11.34	10.20	0.00	6.80	1.13	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	1755.09	45.52	0.00	20.23	0.00	0.00	5.06	5.06	10.12
Myoblast, donor1	11241-116D8	713.82	19.38	4.97	2.98	2.86	0.25	3.98	1.74	0.50
Myoblast, donor2	11322-117D8	684.68	23.40	9.78	11.32	4.79	1.34	4.79	2.49	0.96
Myoblast, donor3	11398-118D3	822.32	23.88	7.74	2.02	2.86	0.84	1.51	1.85	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	35.75	12.99	2.63	0.44	1.02	1.75	0.15	0.00	0.15
Natural Killer Cells, donor1	11230-116C6	187.28	29.21	3.69	0.62	1.85	8.61	0.92	0.00	0.31
Natural Killer Cells, donor2	11311-117C6	74.79	18.39	2.11	2.11	3.62	11.46	1.81	0.00	0.30
Natural Killer Cells, donor3	11387-118C1	158.29	27.42	3.87	1.10	3.87	10.49	1.66	0.92	0.00
Neural stem cells, donor1	11275-116H6	74.04	16.70	14.15	1.45	5.44	1.09	0.36	0.73	0.00
Neural stem cells, donor2	11352-117H2	379.35	36.59	11.55	1.93	7.70	7.70	0.00	0.00	0.00
Neurons, donor1	11494-119E9	279.92	17.07	11.38	3.41	5.69	5.69	0.00	0.00	0.00
Neurons, donor2	11574-120E8	66.93	12.33	7.49	0.66	3.96	4.62	0.00	1.10	0.00
Neurons, donor3	11655-122E8	268.03	14.80	4.93	4.93	6.58	3.29	0.00	0.00	0.82
Neutrophils, donor1	11233-116C9	8477.33	1608.23	5.57	109.50	193.03	21.34	27.84	30.62	20.42
Neutrophils, donor2	11314-117C9	5171.60	1017.51	5.80	171.03	159.44	11.60	72.47	14.49	43.48
Neutrophils, donor3	11390-118C4	11691.52	2436.65	9.77	121.56	191.80	23.21	12.83	36.65	10.38
Nucleus Pulposus Cell, donor1	11252-116F1	585.72	36.21	5.58	1.90	4.27	1.19	2.85	1.31	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	231.83	8.14	5.54	2.93	1.95	1.95	1.95	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	150.21	16.65	4.41	0.80	1.60	0.20	0.20	0.80	0.20
Olfactory epithelial cells, donor1	11933-125I7	158.16	13.77	5.64	1.38	5.09	0.69	1.10	0.83	0.41
Olfactory epithelial cells, donor2	11934-125I8	102.33	12.01	4.34	2.32	3.47	0.43	1.30	0.14	0.14
Olfactory epithelial cells, donor3	11935-125I9	95.46	11.69	8.17	1.36	4.20	0.45	0.79	0.34	0.34
Olfactory epithelial cells, donor4	11936-126A1	109.57	16.27	5.65	0.88	3.12	0.19	0.68	0.49	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	34.91	4.81	4.21	0.00	1.81	0.00	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	302.24	16.80	5.10	3.40	5.32	0.21	0.00	1.28	0.00
Osteoblast - differentiated, donor2	11353-117H3	205.76	10.29	3.43	9.14	4.57	0.00	0.00	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	191.80	9.93	2.48	1.86	3.72	0.00	0.00	0.62	0.62
Osteoblast, donor1	11277-116H8	4.10	2.74	7.62	0.00	0.59	1.17	0.00	0.20	0.00
Osteoblast, donor2	11354-117H4	14.75	4.21	4.21	0.00	2.11	0.70	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	39.10	7.29	7.82	0.53	1.60	0.71	0.00	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	356.48	18.62	12.38	3.03	5.14	0.93	3.03	1.52	0.59
Pericytes, donor1	11491-119E6	8.23	1.67	3.34	0.00	1.00	2.89	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	1.58	2.26	4.30	0.00	1.13	1.81	0.00	0.00	0.23
Pericytes, donor3	11652-122E5	21.16	4.68	5.09	0.41	1.22	0.61	0.00	0.20	0.00
Perineurial Cells, donor1	11499-119F5	5.99	4.86	3.16	0.00	1.70	1.58	0.11	0.23	0.00
Perineurial Cells, donor2	11579-120F4	147.86	18.77	3.31	0.37	2.39	1.20	0.46	0.74	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	273.80	62.15	6.37	1.27	4.14	3.82	0.96	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	691.98	92.56	7.59	10.77	9.79	7.84	4.41	2.20	1.96
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	981.88	80.11	7.51	5.82	8.93	3.88	1.94	1.42	1.42
Placental Epithelial Cells, donor1	11278-116H9	6.94	0.48	5.50	0.48	0.72	1.43	0.00	0.24	0.00
Placental Epithelial Cells, donor2	11355-117H5	2.22	5.54	2.22	1.11	1.11	3.33	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	15.51	1.77	5.69	0.00	1.77	0.98	0.00	0.20	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	43.67	1.90	2.22	1.58	1.90	0.32	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	122.87	3.75	2.81	0.56	1.69	0.00	0.00	0.56	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	49.73	4.70	1.96	0.13	0.91	0.26	0.13	0.39	0.00
Preadipocyte - breast, donor2	11328-117E5	55.84	5.85	3.83	1.13	3.15	0.68	0.23	0.00	0.68
Preadipocyte - omental, donor1	11468-119C1	97.18	6.50	5.86	0.53	3.52	0.00	0.21	0.75	0.21
Preadipocyte - omental, donor2	11329-117E6	80.75	5.67	2.18	0.44	0.87	2.18	0.00	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	105.43	4.30	3.15	0.57	2.86	0.00	1.00	0.43	0.57
Preadipocyte - perirenal, donor1	11469-119C2	110.24	5.91	6.89	1.97	1.97	0.00	0.00	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	56.82	6.45	9.52	0.31	1.54	0.61	0.00	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	153.53	17.18	8.50	2.83	4.43	0.18	0.53	1.42	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	105.41	12.43	5.45	1.36	4.26	0.51	0.68	0.51	0.34
Preadipocyte - visceral, donor1	11280-116I2	215.08	15.09	8.76	0.93	3.07	0.75	0.37	0.75	0.37
Preadipocyte - visceral, donor2	11357-117H7	465.24	19.33	6.44	7.36	5.06	0.46	2.30	0.92	1.84
Preadipocyte - visceral, donor3	11429-118G7	89.13	9.93	6.90	0.94	1.78	0.52	0.42	0.52	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	33.79	16.74	8.60	0.45	4.07	4.22	0.45	0.00	0.15
Prostate Epithelial Cells, donor2	11331-117E8	56.20	5.42	1.62	0.81	1.08	0.81	0.14	0.41	0.68
Prostate Epithelial Cells, donor3	11404-118D9	9.80	4.47	1.96	0.37	2.33	1.29	0.24	0.43	0.06
Prostate Stromal Cells, donor1	11254-116F3	77.34	14.24	7.29	0.34	1.59	1.03	0.46	0.34	0.57
Prostate Stromal Cells, donor2	11332-117E9	257.29	18.11	6.45	3.41	2.87	0.90	1.26	1.26	1.26
Prostate Stromal Cells, donor3	11405-118E1	864.86	33.47	12.72	8.45	7.40	0.52	3.34	2.71	2.82
Renal Cortical Epithelial Cells, donor1	11516-119H4	73.00	5.11	5.11	0.73	4.01	2.19	0.36	0.73	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	63.77	10.60	3.19	0.14	2.91	0.90	0.55	0.14	0.07
Renal Epithelial Cells, donor1	11517-119H5	12.17	3.55	3.55	0.00	0.00	1.52	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	32.72	6.40	4.27	1.42	2.85	2.13	1.42	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	142.07	18.63	4.23	0.53	5.50	0.64	0.21	0.64	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	10.89	4.77	4.09	0.00	0.00	2.04	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	13.07	3.77	2.56	0.13	1.75	0.94	0.13	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	49.06	8.21	4.66	0.89	2.00	1.11	0.44	0.22	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	21.29	2.00	2.66	1.33	1.33	0.67	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	14.53	2.86	5.50	0.00	1.10	2.64	0.22	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	4.39	2.51	5.64	0.63	4.39	1.88	0.63	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	19.42	2.50	5.83	0.00	1.11	0.83	0.28	0.28	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	180.11	17.72	4.29	0.00	5.91	1.07	0.27	0.54	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	174.16	14.76	2.11	2.95	5.90	1.27	1.69	0.84	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	19.86	7.71	4.63	0.58	2.70	1.93	0.39	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	13.22	10.63	4.41	0.00	1.81	3.11	0.52	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	5.40	5.12	5.68	0.28	2.84	1.42	0.00	0.57	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	6.17	1.03	3.09	1.03	0.00	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	48.68	8.53	2.51	0.00	4.52	1.51	0.00	0.75	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	735.00	71.36	10.42	6.41	7.08	2.81	2.54	2.00	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	14.29	7.15	4.47	0.00	2.68	13.40	0.00	1.79	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	15.41	10.46	11.56	2.75	1.65	4.95	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	10.44	9.86	1.16	0.00	2.32	6.96	0.00	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	11.70	16.90	6.50	0.26	2.60	3.25	0.00	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	21.55	15.00	11.22	0.99	3.97	2.28	0.30	0.10	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	23.42	19.85	16.84	0.45	4.35	3.57	0.00	0.67	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	20.72	20.47	11.29	1.86	2.60	4.09	0.00	0.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	20.05	17.60	7.81	0.93	3.73	3.61	0.58	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	23.81	15.95	11.33	0.92	3.00	3.70	0.23	0.46	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	10.95	11.77	6.16	0.00	3.29	2.74	0.00	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	16.49	20.42	11.35	0.91	2.27	1.82	0.00	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	24.55	19.17	14.69	0.00	3.94	3.94	0.00	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	15.21	14.06	8.32	0.43	2.73	2.44	0.14	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	22.86	16.20	9.12	0.64	3.65	2.25	0.54	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	24.12	17.92	13.05	0.89	2.43	2.66	0.22	0.44	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	15.68	11.09	7.84	0.38	2.87	0.96	0.00	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	17.14	14.72	9.60	0.56	2.52	2.42	0.19	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	28.00	19.17	15.03	0.19	4.51	3.95	0.19	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	13.93	12.74	7.83	0.53	3.05	2.65	0.13	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	16.45	17.62	10.80	0.29	3.21	2.24	0.29	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	26.93	17.38	15.47	0.57	2.86	4.01	0.38	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	10.57	12.49	10.04	0.43	2.67	2.24	0.00	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	19.06	15.14	7.85	0.56	4.77	1.96	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	20.17	16.41	12.65	0.85	3.25	3.25	0.17	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	13.13	13.67	10.03	0.55	3.10	2.92	0.00	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	17.54	15.57	10.06	0.61	2.94	2.82	0.12	0.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	20.15	17.06	15.45	0.81	2.96	2.96	0.27	0.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	18.16	10.61	12.97	0.00	2.59	4.72	0.00	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	21.43	18.25	11.71	1.19	2.58	1.98	0.20	0.40	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	21.98	16.37	14.26	0.70	6.08	3.27	0.47	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	17.83	12.23	11.40	0.21	1.87	1.87	0.21	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	23.67	18.58	12.17	3.32	3.54	2.88	0.22	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	24.65	15.46	14.20	0.84	2.72	4.80	0.21	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	17.77	11.71	10.36	0.13	3.50	2.83	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	20.95	15.16	8.17	0.17	3.58	1.36	0.34	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	25.45	14.85	13.30	0.96	4.05	3.28	0.39	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	21.49	12.21	8.94	0.52	3.78	3.61	0.00	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	21.40	16.05	8.37	0.41	3.84	3.02	0.27	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	31.68	15.92	11.33	0.49	4.10	2.96	0.16	0.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	14.83	10.23	6.31	0.17	2.90	4.60	0.17	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	20.86	17.16	11.10	0.59	4.44	2.96	0.59	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	21.06	13.06	9.60	0.53	4.00	4.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	8.57	12.44	7.33	0.14	3.46	5.67	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	12.14	17.14	11.91	1.19	4.76	2.62	0.24	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	20.36	11.08	11.08	0.20	3.22	4.64	0.00	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	7.63	10.26	9.51	0.57	2.64	5.46	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	19.56	17.47	12.58	1.40	3.49	4.54	0.35	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	14.51	9.07	10.28	0.91	4.23	3.93	0.30	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	14.93	14.07	12.12	0.61	3.18	5.39	0.12	0.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	18.63	21.83	20.67	0.15	4.37	7.71	0.44	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	10.95	14.60	12.78	0.00	3.65	7.91	0.00	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	15.67	12.36	12.66	0.30	4.82	5.43	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	13.35	13.80	10.63	1.36	4.52	9.05	0.23	0.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	14.98	15.28	12.88	0.30	4.49	7.79	0.60	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	9.68	13.58	8.27	0.83	3.66	6.14	0.12	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	17.72	13.45	12.17	3.20	2.13	5.34	0.00	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	14.42	17.43	13.82	0.60	5.41	7.81	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	16.36	3.39	5.83	0.00	1.50	1.69	0.00	0.00	0.19
Schwann Cells, donor2	11578-120F3	17.01	6.80	3.40	0.00	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	31.11	4.60	6.79	0.44	2.41	1.31	0.44	0.22	0.22
Sebocyte, donor1	11220-116B5	219.11	13.69	0.55	0.00	2.19	1.64	0.00	1.64	1.10
Sebocyte, donor2	11301-117B5	93.75	6.89	3.68	0.00	2.30	1.38	0.46	0.00	0.46
Sebocyte, donor3	11378-118B1	894.53	21.23	5.36	5.36	12.37	1.44	1.24	6.60	1.86
Sertoli Cells, donor1	11255-116F4	892.91	29.82	6.63	6.63	3.31	1.66	1.66	0.00	1.66
Sertoli Cells, donor2	11333-117F1	220.30	16.95	0.00	8.47	2.82	2.82	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	499.80	24.63	8.45	2.11	8.36	1.41	1.94	2.11	0.53
Skeletal Muscle Cells, donor2	11358-117H8	57.10	5.78	10.84	0.72	2.17	0.72	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	16.72	7.52	10.03	0.84	3.34	0.84	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	103.68	11.31	4.40	0.47	2.36	1.10	0.47	0.16	0.00
Skeletal Muscle Cells, donor5	11455-119A6	92.90	12.34	4.31	1.34	2.23	2.38	0.30	0.30	0.15
Skeletal Muscle Cells, donor6	11459-119B1	194.22	14.31	4.46	2.62	2.62	2.15	0.15	0.77	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	686.23	32.13	13.10	2.39	6.55	3.53	2.65	2.14	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	427.35	21.40	8.70	4.85	4.14	1.71	2.00	0.71	1.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	298.72	17.46	7.24	2.28	4.76	2.38	1.09	0.89	1.19
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	46.84	8.51	6.99	0.34	4.72	0.67	0.34	0.25	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	20.27	7.96	7.24	0.72	2.17	0.72	0.00	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	15.14	3.03	5.78	0.55	0.55	1.24	0.00	0.00	0.00
Skin - palm, donor1	10286-104F7	410.97	29.55	5.37	5.37	5.37	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	50.17	6.63	2.02	0.43	1.73	0.43	0.29	0.43	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	66.25	9.81	7.36	0.82	2.45	6.54	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	74.52	4.02	2.47	0.13	1.56	0.52	0.13	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	125.66	12.37	1.39	0.83	2.09	1.53	0.56	0.42	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	80.32	12.66	2.95	0.98	2.25	1.41	0.98	0.42	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	121.16	9.30	14.17	0.00	2.75	5.29	0.42	0.00	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	84.99	7.27	2.47	0.75	2.40	1.35	0.90	0.15	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	80.23	4.32	5.25	2.16	1.54	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	60.25	5.11	3.56	0.89	0.44	0.89	0.00	0.00	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	440.87	32.33	5.88	1.76	2.35	0.59	0.00	0.59	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	600.43	28.95	3.09	0.66	2.21	0.88	0.44	0.88	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	369.76	16.93	2.36	0.00	1.58	0.00	0.79	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	585.61	28.58	7.73	2.32	4.64	0.77	0.77	2.32	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	58.04	14.01	8.01	1.00	2.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	464.57	21.82	2.79	1.33	1.60	1.20	0.80	1.06	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	386.57	20.61	6.21	3.32	5.10	0.44	3.10	0.89	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	519.68	32.90	4.61	7.43	3.58	0.26	0.51	1.54	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	37.77	6.51	5.21	0.33	1.95	1.63	0.00	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	49.02	5.61	5.61	0.89	2.07	0.59	0.30	0.59	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	412.71	15.38	5.98	1.42	2.70	0.57	1.00	0.85	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	38.23	3.74	6.18	0.00	1.63	0.98	0.00	0.49	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	351.32	15.53	10.66	1.83	6.39	0.30	2.13	1.22	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	333.38	22.23	7.07	0.76	1.77	0.51	0.00	0.76	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	379.48	6.12	12.24	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	465.39	30.52	5.25	5.72	3.34	0.95	0.00	0.48	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	282.71	20.20	9.14	1.33	2.06	1.33	2.21	0.44	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	108.70	10.55	5.60	2.15	3.23	1.08	0.43	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	153.76	12.28	6.61	2.20	1.99	1.47	0.42	0.42	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	325.44	15.00	2.78	1.08	1.55	0.31	0.00	0.46	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	115.33	12.93	8.62	1.08	2.16	0.00	2.16	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	489.53	33.17	5.08	5.68	2.39	0.60	0.00	0.60	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	31.41	4.10	2.73	0.00	1.02	0.34	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	154.31	22.77	5.50	0.86	2.83	1.65	0.86	0.39	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	27.78	9.16	4.83	0.91	2.42	0.50	0.40	0.10	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	3721.17	106.72	7.28	22.07	14.34	1.59	26.85	7.05	10.24
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	422.06	21.13	2.42	8.45	1.81	2.42	0.00	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	80.80	15.37	5.83	0.53	2.38	1.59	0.00	0.26	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	84.69	13.72	7.86	0.53	2.40	1.20	0.00	0.00	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	268.60	18.91	9.02	4.13	5.26	1.13	1.38	0.75	2.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	419.81	11.67	9.13	1.52	4.82	0.25	0.25	1.78	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	35.88	4.67	2.86	0.15	2.11	1.21	0.00	0.30	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	234.05	9.75	3.75	2.25	2.25	0.75	3.00	1.50	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	12.92	5.17	3.88	0.00	1.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	137.66	11.63	7.44	0.00	3.72	0.00	0.00	1.40	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	742.18	41.91	5.05	5.55	7.07	0.50	5.05	1.01	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	881.58	39.17	5.33	12.22	1.88	0.31	1.88	0.94	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	94.40	2.65	2.06	0.59	1.47	0.59	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	25.99	10.08	3.42	0.08	1.17	0.75	0.08	0.17	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	133.61	12.15	3.27	0.47	2.80	0.47	0.00	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	187.96	17.27	4.32	0.86	2.16	0.29	0.00	0.72	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	384.47	20.40	5.35	2.55	2.80	0.76	1.53	0.25	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	26.70	3.76	3.57	0.38	0.56	1.13	0.00	0.38	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	80.35	5.87	2.93	0.42	1.68	0.84	0.42	0.14	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	207.88	13.57	2.35	0.59	3.35	0.08	0.34	0.75	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	337.14	7.14	4.29	0.95	3.33	0.00	1.43	0.95	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	158.79	22.02	4.40	0.98	1.96	0.24	0.24	0.49	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	312.20	10.83	5.74	2.43	3.09	0.66	0.22	1.10	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	28.97	2.93	5.56	0.00	0.00	1.46	0.00	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	146.94	13.80	7.00	1.75	2.72	0.00	0.58	1.17	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	144.13	2.64	6.88	1.59	2.91	0.26	0.79	0.00	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	102.66	10.79	2.60	4.84	2.23	0.37	1.12	0.37	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	623.81	20.48	8.62	7.55	8.26	0.72	1.44	0.00	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	295.54	6.25	9.37	1.14	1.70	0.57	0.28	0.85	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	21.27	8.27	2.36	0.00	0.39	0.00	0.39	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	915.75	20.06	4.32	17.78	7.11	0.25	2.29	1.52	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	1566.93	45.12	9.58	14.77	11.58	0.80	5.19	2.00	4.79
Smooth muscle cells - airway, control, donor3	11968-126D6	667.55	18.39	8.36	7.94	9.20	0.00	3.34	0.84	2.09
Smooth muscle cells - airway, control, donor4	11969-126D7	274.10	15.13	4.58	1.83	4.58	0.46	3.21	0.92	0.46
Synoviocyte, donor1	11291-117A4	266.45	13.30	7.41	0.84	4.71	0.00	0.67	1.18	0.34
Synoviocyte, donor2	11368-117I9	3115.30	108.29	10.73	26.99	18.27	1.01	20.45	7.71	9.55
Synoviocyte, donor3	11440-118H9	2190.09	83.56	10.28	21.67	17.20	0.00	6.26	8.94	2.23
Trabecular Meshwork Cells, donor1	11532-120A2	5.36	6.07	4.29	0.00	1.79	2.14	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	45.59	7.93	7.93	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	1.62	2.32	5.56	0.46	0.93	1.85	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	25.95	4.09	2.15	0.22	0.86	1.36	0.14	0.14	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	27.06	5.03	1.55	0.00	0.77	1.55	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	37.80	5.15	1.72	0.57	0.57	1.15	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	721.54	70.98	11.81	7.14	7.63	2.71	1.72	1.97	1.11
Urethra, donor2	10319-105A4	176.25	23.38	16.19	1.80	1.80	1.80	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	22.58	3.19	1.59	0.00	1.33	1.33	0.27	0.00	0.00
Urothelial Cells, donor2	11600-120H7	60.89	6.81	0.80	0.80	0.80	0.80	0.80	0.00	0.00
Urothelial Cells, donor3	11681-122H7	18.11	1.83	2.52	0.00	0.69	0.23	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	22.96	4.90	2.01	0.00	0.00	0.67	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	1999.34	514.29	2.67	8.90	44.49	5.34	1.78	12.46	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	2406.04	546.11	4.29	8.58	48.61	10.01	1.43	7.15	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	1848.20	348.42	7.53	31.49	49.97	6.16	10.27	10.95	4.79
Whole blood (ribopure), donor090325, donation1	12176-128I7	1339.82	280.64	5.17	6.20	36.50	6.89	5.51	8.61	1.38
Whole blood (ribopure), donor090325, donation2	12177-128I8	1723.33	332.35	8.72	8.72	45.32	5.23	5.23	7.55	4.07
Whole blood (ribopure), donor090612, donation1	12182-129A4	2316.76	510.21	3.12	6.25	44.77	6.25	0.00	7.29	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	1835.58	440.54	2.75	10.10	43.14	3.67	0.92	4.59	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	1841.32	342.34	2.74	30.13	40.17	1.83	6.39	8.22	4.56
Wilms' tumor cell line:G-401	10809-111A8	12.83	10.12	10.98	0.37	1.73	4.69	0.12	0.25	0.12
Wilms' tumor cell line:HFWT	10597-108E3	8.80	8.80	6.16	0.88	4.40	1.76	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	79.05	26.26	2.79	0.28	3.35	1.40	0.28	0.00	0.28
achilles tendon, donor2	10292-104G4	1775.15	78.53	4.13	12.40	8.27	4.13	10.33	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	10.20	4.84	2.55	0.25	0.25	0.76	0.00	0.00	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	94.96	44.35	8.36	0.23	2.32	3.71	0.70	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	34.07	18.52	12.94	0.36	2.14	8.31	0.12	0.24	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	27.21	21.50	6.53	0.00	3.27	2.18	0.82	0.27	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	81.80	45.25	6.18	1.69	3.94	6.46	0.28	0.56	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	32.78	30.45	8.04	0.21	2.11	10.79	0.21	0.21	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	24.50	10.89	5.44	0.54	1.91	6.53	0.00	0.27	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	13.66	18.95	4.41	1.32	0.88	4.41	0.00	0.44	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	91.88	51.45	15.11	1.63	4.49	11.03	0.82	0.82	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	28.35	12.04	9.71	0.39	1.16	5.82	0.39	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	14.17	17.66	3.86	0.92	2.76	4.78	0.18	0.18	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	11.70	7.80	7.80	0.00	0.00	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	9.76	9.30	3.25	0.23	0.70	0.93	0.23	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	28.22	39.61	11.65	1.29	6.47	5.70	0.78	0.52	1.04
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	24.84	28.93	14.61	0.29	4.09	8.77	0.00	0.29	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	12.08	8.83	4.65	0.00	1.86	3.25	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	14.39	12.75	4.11	0.41	2.88	0.41	1.23	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	6.14	4.60	4.60	0.00	0.61	1.84	0.31	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	5.12	8.96	6.40	0.85	1.71	4.27	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	7.89	8.19	9.10	0.00	3.03	4.85	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	9.39	10.59	5.05	0.00	2.17	2.89	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	14.03	11.58	3.56	0.00	0.67	2.23	0.00	0.22	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	12.34	5.67	3.67	0.33	0.67	3.00	0.00	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	27.87	33.45	7.43	0.00	3.72	1.86	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	61.02	29.76	6.03	0.75	3.77	2.26	0.38	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	112.96	30.97	10.47	1.31	5.23	3.05	0.44	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	48.74	5.62	5.62	0.00	1.87	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	28.26	22.14	6.12	0.24	2.59	5.65	0.47	0.24	0.24
adipose tissue, adult, pool1	10010-101C1	1367.69	117.74	10.39	11.79	12.10	0.93	1.55	3.72	0.93
adipose, donor1	10184-103D4	5.28	8.80	7.62	2.93	4.69	24.63	1.17	0.59	0.00
adipose, donor2	10185-103D5	7.30	9.73	5.27	0.41	3.65	17.03	0.00	0.00	0.41
adipose, donor3	10186-103D6	13.89	8.44	10.07	0.54	5.17	10.89	1.09	0.27	0.82
adipose, donor4	10187-103D7	8.67	4.33	4.33	0.87	4.33	6.93	0.87	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	10.42	7.58	8.21	0.32	2.84	4.26	0.63	0.47	0.00
adrenal gland, adult, pool1	10081-102A9	138.23	47.29	7.28	3.64	0.00	7.28	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	9.47	9.74	3.47	0.13	1.47	2.80	0.53	0.00	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	22.15	16.08	10.00	0.71	3.22	2.50	0.36	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	21.10	4.41	2.78	0.00	2.78	1.62	0.00	0.46	0.00
amniotic membrane cells, donor2	12236-129G4	24.01	9.80	9.13	0.68	2.37	2.37	0.34	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	5.30	3.54	4.71	0.29	5.89	1.47	0.00	0.29	0.00
amygdala - adult, donor10196	10167-103B5	86.56	17.79	5.93	3.56	9.49	3.56	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	122.27	34.27	16.63	1.82	10.14	1.82	4.26	0.41	0.20
amygdala, newborn, donor10223	10360-105E9	595.83	12.27	6.46	3.23	4.20	3.55	6.78	0.65	3.55
anaplastic carcinoma cell line:8305C	10428-106D5	716.36	40.24	3.57	2.29	4.07	1.40	3.06	0.76	1.91
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	82.07	34.64	3.53	1.10	3.09	2.65	1.10	0.00	1.10
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	25.05	24.38	10.36	0.00	3.34	14.36	1.34	0.00	0.67
aorta, adult, pool1	10052-101G7	204.76	25.11	3.92	2.35	6.47	2.16	0.98	0.98	0.59
appendix, adult	10189-103D9	483.21	31.05	8.15	4.66	0.78	2.72	1.16	0.78	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	8.25	8.25	10.32	0.34	2.06	8.94	1.03	0.00	0.00
artery, adult	10190-103E1	134.51	48.91	1.36	2.72	1.36	0.00	6.79	0.00	2.72
astrocytoma cell line:TM-31	10425-106D2	113.29	20.28	11.01	0.58	4.49	2.32	0.87	0.14	0.14
b cell line:RPMI1788	10427-106D4	19.78	16.21	2.53	0.15	0.74	2.83	0.15	0.15	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	22.47	8.60	2.77	0.00	1.66	0.00	0.00	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	23.32	9.72	3.87	0.00	0.89	0.69	0.20	0.00	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	304.29	29.46	5.19	0.84	2.51	1.84	2.18	0.84	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	1.68	7.83	7.27	0.56	1.12	1.12	1.68	0.00	0.00
bladder, adult, pool1	10011-101C2	733.22	102.56	4.45	8.15	12.06	1.41	1.41	1.41	0.65
blood, adult, pool1	10053-101G8	695.39	159.45	0.00	15.50	17.72	0.00	2.21	8.86	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	43.67	7.71	4.28	0.00	0.00	0.86	0.00	0.00	0.00
bone marrow, adult	10192-103E3	126.19	33.07	8.77	4.05	4.05	1.35	0.67	0.00	0.00
brain, adult, donor1	10084-102B3	24.60	18.45	2.05	1.03	12.30	3.08	1.03	0.00	0.00
brain, adult, pool1	10012-101C3	91.65	31.51	3.90	3.12	7.91	2.34	0.67	0.89	0.33
brain, fetal, pool1	10085-102B4	18.70	2.67	5.34	0.00	13.36	10.69	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	3.96	4.29	7.27	0.00	2.64	2.97	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	2.37	1.37	3.62	0.00	2.12	4.62	0.00	0.00	0.00
breast, adult, donor1	10080-102A8	459.00	51.77	3.16	7.58	5.05	1.26	0.63	0.63	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	15.12	5.84	7.24	0.38	1.78	2.16	0.38	0.25	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	2.78	3.40	2.78	0.31	1.55	1.86	0.31	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	5.53	4.83	3.91	0.46	0.46	2.76	0.00	0.00	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	15.25	9.44	7.26	0.24	3.87	3.15	0.24	0.48	0.73
carcinoid cell line:NCI-H1770	10703-109H1	13.16	14.11	3.76	0.00	2.82	13.16	1.88	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	16.19	11.59	7.22	0.33	1.64	2.84	0.00	0.00	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	10.77	5.39	2.54	0.32	2.22	1.27	0.95	0.00	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	10.65	7.99	11.18	0.27	1.86	4.26	0.80	0.00	1.06
caudate nucleus - adult, donor10196	10177-103C6	415.63	33.39	8.06	9.21	5.76	4.61	0.00	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	245.47	49.70	11.88	4.35	9.20	3.01	2.68	0.50	1.34
caudate nucleus, adult, donor10258	10379-105H1	27.51	28.27	12.23	3.06	3.82	3.82	0.76	0.00	1.53
caudate nucleus, newborn, donor10223	10354-105E3	1383.63	33.69	8.42	7.32	5.86	3.66	9.16	1.83	5.13
cerebellum - adult, donor10196	10173-103C2	49.53	17.48	2.91	0.00	20.39	2.91	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	74.09	32.03	14.09	1.49	11.32	6.62	1.07	0.21	0.00
cerebellum, adult, pool1	10083-102B2	15.87	14.14	3.79	3.10	4.48	6.55	1.38	0.00	0.34
cerebellum, newborn, donor10223	10357-105E6	59.78	8.30	17.44	0.00	3.32	19.10	1.66	0.00	1.66
cerebral meninges, adult	10188-103D8	45.64	21.18	7.06	2.27	6.81	2.02	2.52	0.00	1.51
cerebrospinal fluid, donor2	10294-104G6	1726.35	74.55	3.65	18.27	5.12	2.19	2.19	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	15.10	17.11	7.91	0.14	3.88	6.04	0.43	0.29	0.00
cervical cancer cell line:ME-180	10553-107I4	7.13	9.45	4.47	0.17	2.65	2.15	0.33	0.17	0.00
cervix, adult, pool1	10013-101C4	185.83	37.17	8.61	2.31	6.82	1.26	0.73	1.15	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	3836.97	183.79	7.38	11.84	15.19	0.56	15.19	3.07	5.43
chondrosarcoma cell line:SW 1353	10700-109G7	80.99	6.53	3.92	0.00	1.31	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	7.08	4.35	6.34	0.50	1.74	2.11	0.00	0.12	0.00
choriocarcinoma cell line:SCH	10785-110H2	15.16	9.12	6.65	0.12	1.85	9.36	0.37	0.25	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	4.51	2.37	2.61	0.24	4.03	1.90	0.47	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	287.48	11.11	1.99	1.42	1.99	0.57	1.71	1.14	0.28
chorionic membrane cells, donor2	12239-129G7	57.17	6.76	5.87	0.89	1.19	2.88	0.20	0.10	0.10
chorionic membrane cells, donor3	12240-129G8	413.21	13.74	5.49	3.30	2.75	0.00	0.00	1.65	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	35.34	11.11	6.06	1.01	0.00	6.06	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	61.09	28.62	7.68	0.58	2.88	2.69	0.19	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	37.80	18.58	2.96	0.00	4.22	4.01	0.00	0.42	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	23.63	19.52	2.31	1.03	1.28	3.08	0.51	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	19.83	19.35	3.14	0.48	1.69	3.87	0.00	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	23.21	16.49	5.09	0.41	1.43	3.66	0.20	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	19.43	22.67	4.42	0.59	2.65	2.36	1.18	0.29	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	153.25	54.99	11.21	0.00	3.39	6.26	0.26	0.52	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	510.19	39.54	3.66	8.91	2.29	3.20	2.74	0.23	2.06
clear cell carcinoma cell line:TEN	10636-108I6	458.92	27.07	1.74	1.56	1.74	0.87	0.69	0.69	0.35
colon carcinoma cell line:CACO-2	10513-107D9	31.85	25.26	9.15	0.18	2.56	1.46	0.18	0.55	0.55
colon carcinoma cell line:COLO-320	10420-106C6	7.60	16.34	7.60	0.00	1.90	7.60	0.38	0.38	0.00
colon, adult, donor1	10082-102B1	44.03	32.13	16.66	1.19	7.14	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	542.63	55.93	9.17	6.35	9.52	3.41	1.65	2.12	0.47
colon, fetal, donor1	10070-101I7	74.78	11.74	4.33	1.85	3.71	1.85	0.00	0.00	1.85
common myeloid progenitor CMP, donor1	12130-128D6	297.93	59.59	13.75	0.00	36.67	13.75	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	175.26	0.00	50.07	0.00	0.00	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	87.96	10.20	19.12	0.00	0.42	6.37	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	45.43	11.17	7.70	0.60	0.75	4.38	0.30	0.00	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	37.23	7.76	7.90	0.14	0.00	3.10	0.00	0.14	0.14
corpus callosum, adult, pool1	10042-101F6	126.59	29.30	16.58	0.77	6.08	2.76	0.11	0.88	0.00
cruciate ligament, donor2	10295-104G7	2185.03	76.99	12.97	16.21	12.97	1.62	6.48	2.43	4.86
diaphragm, fetal, donor1	10069-101I6	55.38	35.31	7.22	1.61	2.41	0.00	0.80	0.80	0.00
diencephalon, adult	10193-103E4	37.20	17.04	6.96	2.64	3.60	1.68	0.48	0.00	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	12.40	8.95	5.74	0.69	1.84	4.13	0.23	0.23	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	10.77	6.92	5.64	0.00	1.54	1.80	0.00	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	28.65	7.46	3.13	0.00	0.72	2.17	0.24	0.00	0.24
ductus deferens, adult	10196-103E7	50.33	16.94	11.96	2.49	2.49	7.48	1.50	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	17.28	7.20	7.20	0.00	1.44	2.88	2.88	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	40.46	19.13	9.56	0.00	5.89	5.89	1.47	0.00	0.00
dura mater, adult, donor1	10041-101F5	2890.72	119.50	4.62	7.43	19.16	0.74	2.56	11.40	0.91
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	279.81	41.08	15.32	4.00	4.66	8.66	0.89	0.44	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	38.98	14.90	21.78	0.29	6.02	6.30	0.14	0.43	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	14.18	4.93	0.00	0.00	1.23	0.62	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	78.70	5.45	1.82	0.61	0.91	0.91	0.61	0.00	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	12.97	3.70	2.78	0.00	0.62	1.23	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	7.88	3.94	2.63	0.00	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	351.96	35.87	6.03	1.01	5.03	2.01	2.35	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	11.78	3.44	7.43	0.72	0.91	0.36	0.36	0.00	0.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	30.07	13.35	2.41	1.61	4.50	2.09	0.32	0.32	0.48
epidermoid carcinoma cell line:A431	10426-106D3	73.70	15.90	8.45	0.22	5.11	1.11	0.22	0.67	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	65.44	18.59	4.29	0.44	3.30	1.65	0.44	0.22	0.00
epididymis, adult	10197-103E8	327.78	29.51	8.58	6.49	3.35	8.16	3.14	0.21	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	26.43	3.19	4.44	0.00	1.60	1.77	1.24	0.00	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	91.63	9.44	1.97	0.39	0.39	0.39	0.39	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	145.86	21.75	4.98	1.97	2.23	3.15	0.52	0.13	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	134.93	24.21	6.20	0.89	2.46	3.64	0.59	0.49	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	119.87	24.20	6.61	1.46	2.24	1.90	0.67	0.34	0.22
esophagus, adult, pool1	10015-101C6	324.48	56.59	5.31	4.03	8.60	1.17	1.06	1.49	0.53
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	4.51	3.51	6.26	0.00	0.88	1.00	0.13	0.25	0.13
eye - muscle inferior rectus, donor1	10272-104E2	864.42	91.75	12.07	2.41	2.41	0.00	0.00	0.00	4.83
eye - muscle lateral, donor2	10298-104H1	991.08	105.21	10.52	6.31	6.31	0.00	6.31	0.00	2.10
eye - muscle medial, donor2	10299-104H2	130.96	37.21	13.39	0.00	2.98	1.49	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	808.28	52.74	11.46	3.44	6.88	0.00	2.29	3.44	2.29
eye - vitreous humor, donor1	10268-104D7	1244.61	42.26	4.37	11.66	5.83	4.37	4.37	1.46	0.00
eye, fetal, donor1	10054-101G9	78.05	25.93	3.81	0.76	5.85	3.31	0.25	0.51	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	27.70	6.41	5.39	0.00	1.67	1.54	0.26	0.13	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	365.86	30.39	8.78	2.37	2.14	1.42	2.85	0.00	1.42
frontal lobe, adult, pool1	10040-101F4	20.92	21.49	7.88	0.75	9.85	4.41	0.38	0.28	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	26.12	15.31	10.21	0.90	4.20	3.30	1.20	0.60	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	698.30	48.10	7.77	2.47	4.48	0.91	1.37	0.82	1.01
gall bladder, adult	10198-103E9	83.05	20.04	8.93	2.66	4.83	3.14	0.72	0.72	0.24
gamma delta positive T cells, donor1	11937-126A2	8.59	12.88	4.83	0.54	1.61	8.05	0.00	0.00	0.54
gamma delta positive T cells, donor2	11938-126A3	59.01	22.78	6.35	1.12	1.49	6.35	0.75	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	17.95	12.88	6.76	1.06	1.48	3.38	1.06	0.42	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	6.38	4.84	1.93	0.00	1.74	0.97	0.39	0.19	0.00
gastric cancer cell line:AZ521	10549-107H9	7.71	6.72	10.98	0.00	0.66	5.08	0.16	0.33	0.00
gastric cancer cell line:GSS	10560-108A2	12.81	9.15	5.49	0.00	2.75	4.58	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	25.36	11.65	8.45	0.46	2.06	5.94	0.00	0.00	0.23
giant cell carcinoma cell line:LU65	10487-107B1	87.20	27.54	2.07	0.11	1.84	1.84	0.57	0.11	0.46
giant cell carcinoma cell line:Lu99B	10433-106E1	44.79	5.88	2.66	0.00	1.26	0.98	0.00	0.00	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	44.65	10.48	2.99	0.25	3.49	0.75	0.25	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	79.27	11.72	8.87	0.32	3.06	2.11	0.32	0.53	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	80.75	11.24	9.13	0.70	4.07	2.25	1.12	0.14	0.56
glioblastoma cell line:T98G	10485-107A8	14.24	8.94	3.86	0.22	1.66	1.88	0.11	0.00	0.00
glioma cell line:GI-1	10413-106B8	73.81	13.77	5.56	0.29	0.29	1.76	0.00	0.00	0.29
globus pallidus - adult, donor10196	10175-103C4	237.63	37.90	8.02	2.19	5.10	5.10	2.19	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	403.98	62.00	19.77	2.93	10.25	4.64	5.13	1.22	1.95
globus pallidus, adult, donor10258	10367-105F7	60.25	16.43	16.43	0.00	0.00	4.11	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	1198.53	25.05	10.66	5.86	4.80	0.53	8.53	0.53	2.66
granulocyte macrophage progenitor, donor1	12131-128D7	132.15	56.28	22.02	0.00	7.34	7.34	0.00	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	43.71	10.93	0.00	10.93	21.86	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	36.59	5.23	10.45	0.00	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	20.80	4.48	3.52	0.96	2.56	0.32	0.32	0.32	0.64
hIPS +CCl2, biol_rep1	14383-156B9	7.80	3.21	0.92	0.00	3.67	5.51	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	10.06	6.40	0.91	0.91	1.83	1.83	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	7.73	8.37	2.58	0.64	5.15	4.51	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	15.81	4.31	7.19	0.00	5.75	5.75	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	3.43	8.23	4.12	0.69	2.74	2.74	0.00	0.69	0.00
hIPS, biol_rep3	14382-156B8	36.41	16.55	8.83	0.00	6.62	4.41	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	16.95	15.52	4.60	0.29	1.44	4.31	1.15	0.00	0.29
heart - mitral valve, adult	10205-103F7	434.10	56.21	5.98	6.28	5.68	2.09	5.38	0.00	2.09
heart - pulmonic valve, adult	10206-103F8	65.89	67.98	8.37	2.35	6.80	1.57	2.09	0.00	0.52
heart - tricuspid valve, adult	10207-103F9	10462.14	198.17	19.15	78.27	43.30	0.83	185.68	28.31	15.82
heart, adult, diseased post-infarction, donor1	10050-101G5	252.42	56.52	4.08	4.29	4.69	1.84	1.22	0.82	0.20
heart, adult, diseased, donor1	10051-101G6	471.82	132.43	2.98	10.22	8.09	2.13	3.41	0.43	1.28
heart, adult, pool1	10016-101C7	642.56	210.43	5.75	4.37	12.19	1.38	1.38	2.30	0.23
heart, fetal, pool1	10046-101G1	99.60	59.45	7.39	0.82	7.39	2.46	0.31	0.51	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	406.94	18.20	0.62	0.62	5.86	0.31	0.93	0.62	1.85
hepatoblastoma cell line:HuH-6	10633-108I3	16.65	8.32	4.76	0.00	5.95	2.38	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	149.83	37.79	14.03	1.44	5.08	4.31	1.10	0.88	0.77
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	150.38	41.39	16.26	2.06	8.13	5.34	1.21	0.73	0.73
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	174.92	39.41	16.07	1.31	7.48	4.75	0.81	1.62	0.40
hepatoma cell line:Li-7	10484-107A7	85.64	24.91	4.34	0.44	1.67	1.56	0.78	0.22	1.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	11.56	8.44	5.03	0.20	0.90	5.33	0.00	0.10	0.20
hippocampus - adult, donor10196	10169-103B7	157.09	14.19	10.41	0.95	10.41	1.89	3.79	0.00	1.89
hippocampus, adult, donor10252	10153-102I9	111.44	35.11	13.67	2.25	9.39	3.06	3.47	0.61	0.82
hippocampus, adult, donor10258	10374-105G5	14.44	4.48	3.49	1.49	12.45	3.98	0.50	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	1090.92	13.39	4.58	4.93	6.34	1.76	7.40	2.82	2.47
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	15.87	14.04	4.27	1.22	4.88	8.54	1.22	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	10.41	12.17	5.89	1.77	3.93	4.12	0.39	0.59	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	12.95	10.66	4.57	1.27	2.79	4.06	1.27	0.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	2.82	8.46	16.92	1.69	3.38	9.59	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	5.42	8.00	10.33	2.32	2.58	9.55	0.26	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	4.56	4.56	9.11	1.14	2.66	9.87	0.00	0.00	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	22.19	15.77	15.47	2.34	7.59	16.35	0.58	0.58	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	15.73	12.93	15.08	2.80	3.66	17.67	0.00	0.00	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	32.53	10.01	16.68	1.25	4.17	15.43	0.42	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	18.00	13.26	15.15	0.71	4.50	10.66	0.00	0.24	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	23.79	15.11	15.91	1.45	3.54	11.57	0.64	0.00	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	20.87	18.18	22.22	0.67	5.39	12.79	1.35	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	10.95	12.05	5.01	0.63	2.97	4.69	0.47	0.16	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	14.74	8.35	3.93	0.98	0.49	3.93	0.00	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	12.22	7.85	6.98	0.87	4.36	8.73	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	4.20	7.64	15.85	0.76	5.15	19.85	0.00	0.38	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	3.49	5.23	10.47	0.44	5.23	17.01	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	3.00	5.50	11.99	0.00	3.00	22.49	0.50	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	8.29	4.71	5.84	1.51	3.77	15.82	0.00	0.38	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	5.91	10.00	9.09	1.36	5.46	20.46	0.91	0.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	8.14	4.07	7.20	0.31	3.76	22.24	0.31	0.31	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	9.47	8.49	13.06	2.12	7.35	15.35	0.16	0.33	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	11.03	7.55	11.03	1.45	5.23	14.23	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	8.97	8.37	11.06	2.39	6.88	16.44	2.99	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	17.18	17.55	4.25	0.92	8.68	4.62	0.18	0.37	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	13.41	11.70	5.42	0.57	7.42	3.42	0.29	0.57	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	28.58	20.01	6.53	1.22	5.72	4.49	1.22	0.41	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	8.10	10.56	9.86	2.46	2.46	9.86	0.00	0.00	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	6.97	5.70	12.99	1.90	4.12	12.04	0.32	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	7.87	5.75	12.71	0.30	6.05	9.99	0.00	0.61	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	11.38	14.48	7.24	1.03	8.79	15.51	0.52	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	11.29	13.28	10.63	0.00	6.64	21.25	0.00	1.33	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	15.39	8.47	11.54	1.80	6.67	15.39	0.51	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	16.36	11.76	12.53	1.53	8.44	10.99	0.00	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	26.50	15.90	17.42	1.51	7.57	19.69	0.76	0.76	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	16.47	8.74	12.43	2.35	7.06	9.07	0.67	1.01	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	15.94	17.15	5.31	1.45	6.28	4.35	0.00	0.24	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	13.82	14.71	4.90	0.89	6.68	4.46	1.78	0.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	18.05	14.63	4.39	1.46	9.76	5.37	0.98	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	5.20	11.61	13.75	2.44	5.50	11.31	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	16.27	26.03	26.03	16.27	6.51	52.05	0.00	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	9.27	7.94	11.58	3.64	5.30	13.57	1.99	0.33	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	22.44	14.78	10.95	2.74	6.02	22.44	0.55	1.09	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	19.54	7.96	12.67	2.17	5.43	20.99	0.36	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	16.37	14.23	14.95	1.78	5.34	21.00	0.71	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	14.32	8.35	11.93	2.39	5.97	17.90	0.00	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	14.22	11.65	15.71	1.22	8.80	19.77	0.00	0.14	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	14.01	9.43	14.01	1.35	6.20	11.85	0.54	0.27	0.00
immature langerhans cells, donor1	11904-125F5	141.17	18.40	2.42	0.24	0.97	0.73	0.24	0.00	0.00
immature langerhans cells, donor2	11905-125F6	164.76	8.71	4.75	2.38	3.96	7.13	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	31.80	19.97	7.76	0.38	12.78	4.92	0.47	0.66	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	5.53	8.78	7.80	0.00	3.90	3.25	0.00	0.33	0.65
kidney, adult, pool1	10017-101C8	3262.95	99.23	14.22	15.42	17.02	3.00	8.21	12.92	3.20
kidney, fetal, pool1	10045-101F9	557.40	31.62	9.69	1.98	8.56	4.24	0.42	2.48	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	14.91	4.12	2.41	0.00	1.14	0.28	0.14	0.28	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	243.72	40.37	4.98	1.80	2.63	0.83	1.11	0.00	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	16.51	8.44	3.85	0.55	2.57	2.02	0.18	0.18	0.00
left atrium, adult, donor1	10079-102A7	174.90	39.77	5.45	4.36	5.45	1.09	2.18	0.00	2.18
left ventricle, adult, donor1	10078-102A6	540.04	127.93	3.54	6.57	6.07	1.52	2.02	0.51	0.51
leiomyoblastoma cell line:G-402	10721-110A1	95.49	12.31	12.04	0.55	2.19	2.74	1.64	0.55	0.55
leiomyoma cell line:10964C	10569-108B2	492.89	16.53	10.06	7.18	4.31	0.72	2.16	2.87	1.08
leiomyoma cell line:15242A	10570-108B3	85.87	7.07	6.52	2.72	1.09	0.54	0.00	0.00	0.54
leiomyoma cell line:15425	10571-108B4	107.32	9.47	6.56	2.43	1.94	0.73	0.49	0.24	1.21
leiomyosarcoma cell line:Hs 5.T	10722-110A2	488.90	31.75	0.00	0.00	0.00	0.00	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	33.46	9.41	2.09	0.00	4.18	2.09	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	43.45	20.78	4.49	0.24	1.77	2.60	0.00	0.12	0.24
liposarcoma cell line:KMLS-1	10782-110G8	79.20	7.50	4.53	0.31	1.56	0.62	0.47	0.31	0.16
liposarcoma cell line:SW 872	10726-110A6	39.11	8.77	7.55	0.00	2.44	1.34	0.49	0.24	0.00
liver, adult, pool1	10018-101C9	3016.12	154.93	19.12	39.38	18.31	3.57	4.54	9.08	2.27
liver, fetal, pool1	10086-102B5	424.26	31.98	4.70	1.88	5.64	1.88	1.88	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	223.99	38.21	12.69	0.87	6.12	3.06	2.04	0.58	0.73
locus coeruleus, adult, donor10252	10165-103B3	360.80	44.11	14.03	3.69	10.70	1.29	2.77	1.29	0.55
locus coeruleus, adult, donor10258	10375-105G6	58.12	16.65	11.57	3.39	6.49	3.10	0.85	0.85	0.28
locus coeruleus, newborn, donor10223	10362-105F2	2755.89	38.28	6.73	36.17	11.36	2.10	20.19	1.26	6.73
lung adenocarcinoma cell line:A549	10499-107C4	19.79	5.81	1.52	0.14	0.69	0.69	0.28	0.14	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	2.07	2.76	4.83	0.00	0.00	2.07	0.00	0.00	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	11.73	9.10	3.69	0.00	2.11	1.58	0.00	0.26	0.00
lung, adult, pool1	10019-101D1	763.46	92.26	5.32	8.62	7.44	2.72	1.42	1.54	0.71
lung, fetal, donor1	10068-101I5	996.64	95.61	4.85	3.42	5.14	5.14	0.57	0.86	0.57
lung, right lower lobe, adult, donor1	10075-102A3	167.71	27.03	6.42	4.58	4.12	3.67	1.37	0.46	0.92
lymph node, adult, donor1	10077-102A5	794.78	48.28	12.78	12.31	8.05	1.89	2.37	3.31	1.42
lymphangiectasia cell line:DS-1	10727-110A7	8.33	7.45	3.07	0.00	0.66	2.41	0.00	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	20.38	7.70	5.43	0.30	0.15	4.98	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	310.07	16.14	5.95	0.85	5.10	1.70	0.00	0.00	1.70
mature adipocyte, donor1	12231-129F8	2250.58	138.52	15.98	8.88	5.33	0.00	4.00	4.00	0.44
mature adipocyte, donor2	12232-129F9	1535.29	95.67	8.51	6.43	5.60	1.25	3.53	1.87	1.66
mature adipocyte, donor3	12233-129G1	3234.96	110.95	12.56	13.28	6.87	1.42	3.79	4.50	2.37
mature adipocyte, donor4	12234-129G2	2378.17	114.24	9.21	10.79	5.26	1.32	4.74	0.79	1.84
maxillary sinus tumor cell line:HSQ-89	10414-106B9	5.48	6.67	6.67	0.24	5.24	10.01	0.48	0.71	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	50.76	22.56	5.64	2.26	7.90	0.00	2.26	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	159.26	38.99	11.40	3.68	9.01	4.23	2.02	0.55	1.10
medial frontal gyrus, adult, donor10258	10368-105F8	20.65	14.93	5.08	0.64	7.31	1.59	1.91	0.32	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	493.45	20.47	5.54	9.81	5.12	4.26	4.26	0.43	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	44.21	24.13	9.45	4.22	7.93	3.38	1.52	0.84	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	137.10	41.81	12.95	2.33	11.04	2.76	4.03	0.64	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	13.48	7.71	3.85	0.00	5.78	1.93	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	14.35	0.00	0.00	28.71	0.00	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	423.18	13.64	5.03	2.15	6.46	1.08	3.23	0.72	2.15
medulla oblongata - adult, donor10196	10174-103C3	469.21	33.10	10.38	1.95	7.79	1.95	4.54	0.65	0.65
medulla oblongata, adult, donor10252	10155-103A2	372.46	43.65	13.78	4.18	8.05	2.63	1.39	1.70	0.46
medulla oblongata, adult, pool1	10038-101F2	304.71	40.49	8.90	1.14	7.43	2.78	0.33	0.90	0.08
medulla oblongata, newborn, donor10223	10361-105F1	2214.32	36.80	13.89	7.99	12.50	2.78	8.33	4.17	2.08
medulloblastoma cell line:D283 Med	10838-111E1	6.42	12.18	9.08	0.44	6.42	3.76	0.22	0.66	0.00
medulloblastoma cell line:ONS-76	10759-110E3	21.03	7.34	2.57	0.24	0.98	2.20	0.00	0.12	0.00
melanoma cell line:COLO 679	10514-107E1	7.76	6.61	5.75	0.57	1.44	0.72	0.14	0.43	0.00
melanoma cell line:G-361	10465-106H6	2.44	5.43	1.09	0.00	2.17	1.09	0.54	0.00	0.81
meningioma cell line:HKBMM	10691-109F7	434.17	22.97	1.45	9.59	1.81	0.54	4.34	0.36	0.72
merkel cell carcinoma cell line:MKL-1	10843-111E6	1.76	7.05	22.03	0.88	4.41	17.62	0.88	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	28.77	17.89	17.63	1.81	3.63	17.37	0.78	0.52	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	26.39	6.90	6.44	0.00	0.77	0.61	0.15	0.31	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	55.26	6.54	6.36	0.73	1.45	0.36	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	86.13	7.45	7.87	0.83	1.66	0.41	0.41	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	449.52	25.99	7.87	1.83	3.37	0.84	0.84	1.12	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	354.71	26.57	8.28	2.12	2.50	0.19	0.77	1.16	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	1077.90	30.54	6.94	6.25	4.16	2.08	2.08	2.08	2.08
mesenchymal precursor cell - cardiac, donor1	11752-123G6	707.13	39.65	6.35	4.29	4.98	0.17	0.86	2.23	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	273.62	20.93	4.60	2.07	1.96	0.12	0.46	0.46	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	81.57	11.14	5.84	0.27	2.25	0.93	0.13	0.53	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	976.07	44.02	5.94	7.43	3.65	0.00	2.57	2.57	1.62
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	633.21	26.89	4.13	4.84	2.85	0.14	1.99	0.85	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	5340.82	87.28	7.90	30.96	19.10	0.00	14.82	6.59	4.61
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	593.06	23.94	4.70	2.77	3.04	0.42	1.25	0.97	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	61.79	5.59	7.33	1.05	1.40	0.70	0.35	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	50.43	7.35	4.49	0.20	1.43	0.20	0.20	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	477.36	15.46	4.67	3.95	4.31	1.08	1.44	1.08	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	806.91	24.83	2.90	4.86	3.83	0.21	1.24	0.62	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	1059.25	11.63	2.51	9.12	4.10	0.46	3.19	2.28	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	229.50	20.56	5.45	1.26	2.94	0.84	0.42	1.26	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	416.33	16.44	5.08	2.24	2.84	1.05	0.75	1.34	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	490.08	22.58	2.98	3.85	2.19	0.44	1.31	0.18	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	388.41	15.46	4.42	3.31	2.95	0.37	0.37	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	594.92	15.45	3.15	4.86	3.15	0.00	2.58	1.43	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	28.63	14.74	4.21	2.11	3.79	0.42	1.26	0.42	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	83.11	5.02	3.65	1.83	0.00	0.46	0.00	0.00	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	95.92	8.44	7.93	0.77	0.51	1.28	0.26	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	102.35	9.42	5.50	1.05	2.09	1.31	0.52	0.26	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	90.27	8.01	7.39	0.92	2.46	0.31	1.85	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	84.26	7.53	6.35	2.59	0.94	0.47	0.71	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	103.57	7.78	6.77	1.02	2.03	0.34	0.68	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	82.13	7.86	7.86	1.18	0.79	1.18	0.39	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	78.31	6.95	9.73	0.93	0.46	0.46	0.46	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	117.96	9.52	6.63	2.02	2.88	1.44	0.58	0.00	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	110.66	8.03	5.80	0.67	0.89	1.56	1.34	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	115.85	9.61	7.21	1.44	2.64	1.20	0.48	0.96	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	113.67	16.13	5.87	1.47	2.20	0.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	108.08	7.72	9.40	1.01	1.34	1.01	0.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	109.71	4.91	6.14	0.82	2.05	0.41	0.41	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	122.85	8.59	4.73	0.43	1.72	0.43	0.86	0.43	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	150.39	16.41	2.73	2.73	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	134.29	5.16	15.49	0.00	0.00	0.00	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	122.12	10.07	5.85	0.97	1.30	1.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	109.12	8.73	7.27	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	131.14	9.60	7.46	2.13	2.67	0.53	2.13	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	129.21	13.08	3.27	0.82	3.27	1.64	0.82	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	140.72	15.16	8.55	2.72	0.78	1.94	0.39	0.00	1.55
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	136.42	16.79	6.30	0.00	2.10	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	168.89	12.92	2.98	1.99	0.00	1.99	0.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	195.46	9.53	4.77	4.77	0.00	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	154.17	15.42	4.74	1.78	2.37	0.59	1.19	0.00	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	182.77	8.53	6.09	4.87	1.22	1.22	1.22	1.22	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	108.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	155.81	9.50	6.33	0.63	0.63	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	157.28	19.66	8.97	2.76	2.76	0.00	1.38	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	167.64	30.09	15.04	0.00	4.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	139.71	11.98	3.99	0.00	0.00	0.00	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	247.96	27.55	13.78	3.44	3.44	0.00	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	210.25	24.45	6.52	1.63	4.89	0.41	2.85	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	243.10	37.34	5.56	3.97	3.97	0.79	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	202.21	34.19	6.48	2.36	4.72	0.00	3.54	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	214.45	34.91	5.61	1.56	2.49	1.25	2.18	0.62	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	191.14	48.12	8.02	2.67	5.35	1.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	209.33	17.74	14.19	1.18	3.55	1.18	3.55	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	310.73	20.54	10.27	5.14	2.57	0.00	5.14	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	278.80	30.98	6.88	4.13	6.88	1.38	2.07	0.00	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	62.35	15.34	13.85	0.00	2.47	0.49	1.48	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	48.22	8.97	11.22	2.24	1.12	2.24	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	69.97	17.81	14.63	1.27	3.18	0.64	1.91	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	58.03	18.94	12.90	0.81	2.01	0.40	0.81	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	65.42	21.81	10.90	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	45.61	12.67	8.87	1.27	0.00	0.00	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	92.25	30.34	9.71	2.43	1.82	1.21	0.61	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	140.09	31.63	0.00	0.00	0.00	0.00	22.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	76.60	20.59	17.30	0.00	0.82	0.00	2.47	0.82	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	91.47	20.44	10.72	0.60	1.59	0.40	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	85.67	13.30	7.79	1.62	2.60	0.00	1.62	0.00	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	83.53	19.35	13.24	2.04	3.06	1.02	1.02	1.02	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	18.57	1.55	6.96	0.00	1.55	0.00	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	29.53	9.92	1.65	0.00	1.42	0.47	0.71	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	553.70	38.69	6.72	1.62	3.71	2.78	5.56	0.93	1.16
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	517.11	42.74	8.55	4.27	4.27	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	357.88	33.09	5.75	1.75	4.11	3.08	1.85	0.21	0.51
mesothelioma cell line:Mero-25	10850-111F4	97.82	10.89	4.77	0.45	3.63	2.72	0.23	0.00	0.45
mesothelioma cell line:Mero-41	10851-111F5	88.50	9.05	3.91	0.98	1.71	0.73	0.00	0.00	0.49
mesothelioma cell line:Mero-48a	10852-111F6	33.21	9.74	5.76	0.44	1.55	5.09	0.44	0.22	0.44
mesothelioma cell line:Mero-82	10853-111F7	219.71	13.93	4.99	0.79	4.20	0.79	1.31	0.26	0.00
mesothelioma cell line:Mero-83	10854-111F8	46.30	7.15	5.45	1.70	2.55	1.19	0.00	0.51	0.34
mesothelioma cell line:Mero-84	10855-111F9	75.07	10.11	4.04	0.51	2.27	0.51	0.00	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	1023.20	37.89	8.49	5.80	10.97	1.86	3.73	2.28	2.90
mesothelioma cell line:NCI-H2052	10847-111F1	84.65	12.42	3.31	1.16	2.82	1.16	0.33	0.00	0.17
mesothelioma cell line:NCI-H226	10846-111E9	645.60	32.94	6.70	3.62	3.44	1.45	2.90	1.09	1.81
mesothelioma cell line:NCI-H2452	10848-111F2	262.90	17.94	4.27	1.37	2.22	4.10	1.02	0.85	1.20
mesothelioma cell line:NCI-H28	10845-111E8	89.06	18.83	8.65	1.78	1.78	5.09	1.27	0.00	0.51
mesothelioma cell line:No36	10857-111G2	35.23	10.11	4.24	0.00	2.28	0.98	0.33	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	1136.64	41.73	7.32	7.32	9.48	1.35	1.90	1.35	2.17
migratory langerhans cells, donor1	11901-125F2	19.77	7.29	3.45	0.00	0.58	4.61	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	9.53	7.57	2.69	0.00	0.12	1.47	0.00	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	25.85	12.74	2.15	0.36	0.54	3.23	0.18	0.00	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	163.24	43.42	7.84	7.18	7.18	1.31	5.22	0.65	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	176.54	41.96	6.15	2.97	3.18	2.97	1.70	0.85	1.48
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	6.45	4.38	2.76	0.23	0.23	0.23	0.00	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	13.51	6.66	3.04	0.38	1.33	0.95	0.19	0.19	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	9.42	10.53	4.62	0.18	0.92	6.28	0.18	0.00	0.18
myeloma cell line:PCM6	10474-106I6	23.13	12.65	4.15	0.79	0.20	5.93	0.79	0.20	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	15.73	1.01	3.55	0.51	1.01	0.00	0.51	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	714.73	62.37	5.88	2.94	6.47	1.77	2.35	1.96	1.96
nasal epithelial cells, donor1, tech_rep1	12226-129F3	9.03	6.02	1.89	0.11	2.01	0.89	0.22	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	6.77	5.22	2.65	0.29	1.69	1.18	0.07	0.00	0.07
nasal epithelial cells, donor2	12227-129F4	60.72	8.83	6.62	0.00	1.10	0.55	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	4.60	4.37	3.22	0.00	1.61	6.90	0.23	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	8.23	15.34	8.42	0.56	2.43	7.30	1.12	0.19	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	6.12	3.80	2.53	0.00	0.42	3.59	0.42	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	6.89	7.45	11.55	0.19	9.50	9.13	0.19	0.19	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	5.69	5.69	4.03	0.00	1.19	6.88	0.47	0.00	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	11.72	8.71	3.96	0.79	2.22	1.90	0.48	0.00	0.79
neuroectodermal tumor cell line:TASK1	10774-110F9	11.07	12.68	7.45	0.20	3.22	2.62	1.21	0.20	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	8.90	6.36	3.18	0.00	3.18	1.27	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	24.75	3.73	2.93	0.00	1.33	0.00	0.00	0.00	0.00
neutrophil PMN, donor1	12133-128D9	535.49	74.37	14.87	0.00	29.75	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	557.79	13.28	13.28	0.00	0.00	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	511.41	66.29	18.94	0.00	18.94	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	55.30	19.11	6.76	0.34	1.18	16.07	0.68	0.00	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	8.81	12.81	4.80	0.00	0.00	6.40	0.00	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	22.12	8.98	9.94	0.64	2.56	1.60	0.32	0.00	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	147.67	22.60	3.94	4.47	2.10	1.05	2.63	0.00	0.79
nucleus accumbens, adult, pool1	10037-101F1	39.46	23.62	7.97	0.66	8.44	2.72	0.28	0.66	0.09
occipital cortex - adult, donor10196	10172-103C1	65.93	28.85	2.06	0.00	16.48	0.00	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	346.46	45.35	14.49	4.83	12.34	3.76	7.51	1.07	1.61
occipital cortex, newborn, donor10223	10355-105E4	512.07	20.74	8.01	3.28	5.46	1.46	3.64	0.73	1.46
occipital lobe, adult, donor1	10076-102A4	23.35	19.42	2.62	6.04	7.87	1.84	2.62	0.26	3.67
occipital lobe, fetal, donor1	10073-102A1	4.29	5.15	8.58	2.57	9.44	5.58	0.43	0.86	0.43
occipital pole, adult, pool1	10036-101E9	20.81	15.61	3.94	0.55	6.94	1.34	0.08	0.87	0.08
olfactory region, adult	10195-103E6	27.51	18.53	9.93	2.48	6.69	2.10	0.57	0.19	0.38
optic nerve, donor1	10277-104E7	310.16	24.01	10.01	4.00	4.00	0.00	6.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	18.91	10.37	7.52	0.11	1.03	3.65	0.11	0.00	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	76.52	30.09	3.43	0.41	6.32	3.85	0.55	0.55	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	87.88	15.07	3.22	2.03	2.37	0.17	0.85	0.17	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	100.03	11.78	6.93	0.58	2.31	1.27	0.69	0.23	0.46
osteoclastoma cell line:Hs 706.T	10704-109H2	18.23	4.41	0.59	0.29	3.23	0.59	0.00	0.00	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	96.24	16.82	5.61	0.00	0.93	0.93	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	70.40	12.51	5.30	0.21	2.12	1.06	1.06	0.64	0.00
ovary, adult, pool1	10020-101D2	583.77	52.85	6.29	5.59	8.21	2.27	0.35	1.48	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	198.54	10.82	2.02	1.47	1.83	0.37	0.92	0.73	0.55
pancreas, adult, donor1	10049-101G4	300.06	48.91	12.23	4.70	12.23	3.76	2.82	4.70	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	7.83	5.03	6.15	0.28	2.24	1.96	0.00	0.00	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	187.05	21.29	5.28	3.75	4.60	2.04	1.02	0.17	0.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	44.71	9.44	2.98	0.33	1.16	2.32	0.00	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	38.26	20.50	7.23	0.73	9.70	1.92	0.27	0.64	0.09
parietal cortex, adult, donor10258	10373-105G4	26.42	7.34	2.20	0.00	5.14	2.94	0.73	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	63.95	18.81	6.58	1.88	9.40	1.88	2.82	0.94	1.88
parietal lobe, adult, donor10252	10157-103A4	178.15	41.05	6.84	1.43	9.69	1.71	2.57	1.71	0.57
parietal lobe, adult, pool1	10034-101E7	29.34	25.73	5.64	0.88	9.52	3.70	0.26	0.70	0.18
parietal lobe, fetal, donor1	10072-101I9	3.88	3.88	10.67	0.97	5.82	12.61	0.97	0.00	1.94
parietal lobe, newborn, donor10223	10356-105E5	648.65	19.07	7.48	4.49	12.71	3.74	7.10	0.75	0.75
parotid gland, adult	10199-103F1	113.47	26.52	9.25	2.47	1.23	1.23	0.62	0.00	0.62
penis, adult	10200-103F2	121.92	36.52	3.76	4.30	5.91	2.69	1.07	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	75.30	10.60	1.86	0.56	1.12	2.23	0.00	0.37	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	96.74	19.09	3.21	0.58	2.19	1.31	1.02	0.29	0.58
pineal gland - adult, donor10196	10179-103C8	101.27	14.84	7.10	0.00	2.58	4.52	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	190.10	36.12	14.21	0.00	6.51	8.29	0.59	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	33.23	18.81	15.68	1.25	2.51	3.14	0.63	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	136.59	18.21	3.04	3.04	2.02	16.19	0.00	2.02	0.00
pituitary gland, adult, donor10252	10162-103A9	232.45	41.17	15.11	2.08	9.38	15.64	0.52	1.04	0.52
pituitary gland, adult, donor10258	10378-105G9	6.81	6.81	11.07	0.85	4.26	15.32	0.85	0.00	0.85
placenta, adult, pool1	10021-101D3	182.43	13.76	5.59	0.32	2.15	1.29	0.43	0.11	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	15.23	15.76	2.91	0.26	1.99	3.71	0.40	0.13	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	276.73	31.44	2.96	1.40	4.05	1.87	0.93	0.93	0.31
pons, adult, pool1	10033-101E6	77.98	35.80	5.34	0.43	11.02	1.81	0.26	0.69	0.17
postcentral gyrus, adult, pool1	10032-101E5	23.80	20.49	6.54	0.52	7.76	1.83	0.35	0.44	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	27.19	12.55	18.82	0.00	4.18	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	60.59	16.52	5.51	0.00	0.00	5.51	0.00	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	129.09	35.21	0.00	0.00	0.00	23.47	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	52.73	15.73	4.22	0.29	1.31	3.35	0.58	0.00	0.73
prostate cancer cell line:PC-3	10439-106E7	23.41	11.62	6.90	0.36	1.45	1.09	0.18	0.18	0.18
prostate, adult, pool1	10022-101D4	522.75	49.79	10.61	2.90	10.88	1.63	1.45	1.72	0.18
putamen, adult, donor10196	10176-103C5	89.23	34.23	8.26	1.89	6.85	3.30	3.07	0.24	0.94
putamen, adult, donor10252	10152-102I8	211.76	56.86	17.65	0.00	5.88	1.96	3.92	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	24.04	4.37	1.09	0.00	2.19	1.09	1.09	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	32.13	20.78	5.80	0.72	2.90	0.24	0.48	0.24	0.24
putamen, newborn, donor10223	10365-105F5	1410.86	26.24	8.25	19.49	5.25	1.50	11.99	0.75	10.50
rectal cancer cell line:TT1TKB	10469-106I1	35.79	11.35	2.62	0.00	0.00	1.16	0.00	0.58	0.00
rectum, fetal, donor1	10067-101I4	22.26	11.13	19.47	0.00	6.95	2.78	1.39	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	75.47	9.12	3.18	0.21	1.27	0.42	0.64	0.42	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	1952.17	99.41	4.14	10.77	6.63	2.49	26.51	0.83	10.77
retina, adult, pool1	10030-101E3	126.34	38.87	9.64	0.60	7.36	3.58	0.50	0.70	0.20
retinoblastoma cell line:Y79	10475-106I7	16.11	32.48	14.03	0.78	2.86	7.53	1.30	0.00	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	6.64	3.93	5.41	0.37	1.84	2.09	0.12	0.12	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	32.90	52.30	6.75	0.28	5.91	1.69	0.56	1.12	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	219.02	24.25	4.55	0.00	3.03	0.00	1.52	0.00	0.76
salivary acinar cells, donor1	11771-123I7	1264.91	60.70	5.02	8.25	8.25	0.49	4.21	2.10	0.49
salivary acinar cells, donor2	11772-123I8	458.64	40.07	5.09	3.72	7.85	1.79	2.89	0.83	0.14
salivary acinar cells, donor3	11773-123I9	744.81	49.65	4.63	5.96	11.25	0.66	4.63	4.63	0.00
salivary gland, adult, pool1	10093-102C3	277.40	34.89	4.58	1.14	2.29	4.00	0.00	1.72	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	255.38	10.62	1.60	1.43	0.84	0.08	0.67	0.34	0.59
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	229.70	12.46	1.41	0.59	0.94	0.24	0.82	0.71	0.59
seminal vesicle, adult	10201-103F3	35.45	12.17	11.64	1.59	2.65	5.29	1.06	0.00	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	121.71	9.96	10.69	1.70	5.59	2.19	0.49	0.24	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	1310.25	75.49	8.05	14.85	9.06	0.50	1.26	2.52	1.01
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	42.15	11.04	4.01	1.00	7.02	1.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	258.57	30.63	5.10	1.75	11.01	1.88	1.34	1.61	0.81
signet ring carcinoma cell line:Kato III	10436-106E4	21.88	15.47	4.86	0.00	0.99	2.21	0.55	0.00	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	43.22	17.16	6.97	0.26	1.55	0.77	0.65	0.13	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	4116.98	157.47	2.13	24.83	7.09	0.00	9.93	1.42	3.55
skeletal muscle, adult, pool1	10023-101D5	9420.83	295.65	6.60	72.20	32.14	0.84	14.39	15.95	5.52
skeletal muscle, fetal, donor1	10066-101I3	21.11	9.05	1.01	2.01	4.02	0.00	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	47.50	13.57	0.00	0.00	6.79	0.00	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	31.56	18.94	8.21	2.52	5.05	2.52	1.89	0.63	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	14.01	15.68	12.34	0.33	4.00	7.34	1.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	14.81	8.83	10.40	0.95	4.41	14.81	0.95	0.00	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	2.89	0.96	8.87	0.00	1.35	2.89	0.19	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	12.36	13.19	10.88	0.16	4.45	11.37	0.33	0.99	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	14.96	22.52	4.18	0.80	3.54	1.45	0.64	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	49.69	28.11	15.91	0.87	5.45	18.74	0.65	0.22	0.00
small intestine, adult, pool1	10024-101D6	82.77	37.03	7.76	2.03	5.26	3.22	0.60	0.72	0.48
small intestine, fetal, donor1	10064-101I1	33.41	17.20	3.93	0.74	4.91	2.21	0.98	0.00	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	93.35	31.80	6.15	2.56	1.54	9.75	0.51	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	434.20	62.03	5.94	3.62	9.82	1.81	2.07	1.29	0.52
somatostatinoma cell line:QGP-1	10781-110G7	2.68	3.75	1.88	0.00	1.88	0.80	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	228.26	36.02	9.41	2.52	7.34	1.38	1.84	0.92	0.00
spinal cord, adult, donor10252	10159-103A6	684.45	60.32	11.83	4.73	7.89	6.70	3.55	3.15	1.58
spinal cord, adult, donor10258	10369-105F9	55.34	8.99	2.77	0.69	0.69	0.69	0.00	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	20.73	22.56	14.03	0.61	8.54	3.66	3.05	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	2374.59	42.25	13.32	37.20	5.05	4.13	5.51	0.46	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	24.20	6.72	2.54	0.00	1.79	0.15	0.60	0.00	0.30
spleen, adult, pool1	10025-101D7	330.62	41.19	4.96	1.65	3.85	2.20	0.33	0.44	0.44
spleen, fetal, pool1	10044-101F8	283.42	31.15	6.20	0.72	4.61	2.07	0.08	0.87	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	2.07	3.21	1.35	0.10	0.62	1.04	0.10	0.00	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	476.40	48.80	3.61	0.57	4.18	1.71	3.99	0.76	1.14
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	112.87	22.36	11.18	2.80	2.10	2.45	1.40	0.35	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	30.10	5.86	4.69	0.00	1.17	3.52	0.39	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	23.30	10.36	6.87	0.11	1.69	4.39	0.11	0.11	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	9.32	7.20	5.93	0.00	2.54	7.62	0.00	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	28.77	8.46	21.15	0.42	1.27	2.12	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	49.13	20.29	8.54	1.07	4.27	3.20	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	149.26	27.34	10.82	6.27	4.56	4.56	2.85	0.00	1.14
substantia nigra - adult, donor10196	10178-103C7	217.10	0.00	0.00	54.27	0.00	0.00	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	319.04	41.13	14.75	2.49	7.27	5.19	2.70	1.04	0.21
substantia nigra, adult, donor10258	10371-105G2	43.97	11.38	6.21	2.59	4.66	1.55	0.52	1.03	0.00
substantia nigra, newborn, donor10223	10358-105E7	1765.73	26.85	6.36	9.19	9.89	2.12	12.72	4.24	2.12
synovial sarcoma cell line:HS-SY-II	10441-106E9	5.04	8.71	4.59	0.69	1.15	2.06	0.23	0.00	0.23
temporal lobe, adult, pool1	10031-101E4	20.77	16.87	6.87	0.85	8.14	2.54	0.34	0.34	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	1.42	4.27	4.27	0.71	5.70	4.27	2.14	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	12.75	4.40	10.11	1.76	3.08	6.15	0.44	0.00	0.44
tenocyte, donor1	11763-123H8	1703.26	56.21	8.38	19.20	11.87	0.35	11.17	4.89	5.59
tenocyte, donor2	11765-123I1	846.18	43.87	9.54	9.16	8.77	0.00	8.39	0.76	3.43
tenocyte, donor3	11768-123I4	191.26	11.12	7.04	3.34	3.34	0.37	1.48	0.37	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	44.36	27.19	4.25	1.19	4.25	9.52	0.68	0.34	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	4.47	7.86	6.17	0.31	1.23	1.85	0.00	0.15	0.15
teratocarcinoma cell line:PA-1	10807-111A6	4.96	6.35	4.18	0.31	5.11	1.55	0.31	0.15	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	9.90	5.59	2.16	0.63	3.81	1.02	0.13	0.63	0.51
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	2.27	3.40	2.65	0.38	1.13	0.76	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	7.42	4.36	1.42	0.22	0.55	0.33	0.00	0.11	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	8.14	4.89	0.98	0.33	0.98	1.63	0.33	0.00	0.33
testis, adult, pool1	10026-101D8	408.45	41.55	6.98	12.24	5.80	5.58	0.54	1.61	0.43
testis, adult, pool2	10096-102C6	41.05	13.98	6.77	1.80	2.26	6.32	0.00	0.45	0.00
thalamus - adult, donor10196	10168-103B6	290.35	43.06	9.94	2.21	5.52	9.94	5.52	3.31	0.00
thalamus, adult, donor10252	10154-103A1	149.72	37.51	17.03	2.97	7.97	3.44	1.41	0.63	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	113.93	10.78	9.24	3.08	13.86	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	50.56	18.28	7.41	1.32	3.29	0.99	0.82	0.00	0.33
thalamus, newborn, donor10223	10366-105F6	727.20	17.83	4.03	5.18	14.96	2.88	9.78	1.15	2.88
throat, adult	10209-103G2	98.62	44.69	6.74	4.24	4.74	3.75	0.50	0.25	0.25
throat, fetal, donor1	10061-101H7	15.54	16.45	10.06	1.52	5.48	4.27	0.61	0.30	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	3.58	2.58	13.71	0.20	0.99	9.14	0.20	0.00	0.00
thymus, adult, pool1	10027-101D9	41.95	18.59	4.18	0.99	2.49	10.74	0.10	0.40	0.00
thymus, fetal, pool1	10043-101F7	284.91	27.12	7.69	0.83	3.22	9.04	0.31	0.42	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	225.63	23.27	6.38	1.33	2.53	1.46	0.80	0.40	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	20.53	8.66	4.75	0.42	2.10	3.77	0.56	0.14	0.28
thyroid, adult, pool1	10028-101E1	804.17	67.28	8.49	4.01	8.86	3.55	1.12	2.15	0.47
thyroid, fetal, donor1	10060-101H6	18.98	12.92	8.17	1.05	5.27	5.80	1.05	0.26	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	803.78	76.99	6.16	6.16	6.16	3.08	0.00	0.00	3.08
tongue, adult	10203-103F5	303.75	68.84	5.12	9.30	6.28	1.63	2.33	0.93	0.47
tongue, fetal, donor1	10059-101H5	44.53	40.99	4.73	0.79	5.52	3.94	2.76	0.00	1.18
tonsil, adult, pool1	10047-101G2	262.86	37.67	6.61	1.00	6.21	3.21	0.60	1.10	0.10
trachea, adult, pool1	10029-101E2	2471.22	76.89	7.12	10.96	12.84	2.13	2.94	5.97	0.57
trachea, fetal, donor1	10058-101H4	103.48	23.85	7.69	1.92	6.92	5.00	1.92	0.00	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	52.43	10.98	5.31	0.00	4.61	0.71	0.00	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	158.56	21.88	9.93	0.51	2.03	2.13	0.51	0.41	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	846.58	23.35	6.74	4.07	2.35	1.25	5.01	1.72	3.76
tridermal teratoma cell line:HGRT	10694-109G1	98.93	11.42	1.90	0.00	3.81	1.90	1.90	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	105.90	15.49	2.79	0.59	2.20	0.93	0.51	0.08	0.34
umbilical cord, fetal, donor1	10057-101H3	217.00	37.56	6.26	2.09	6.26	0.00	4.17	2.09	2.09
uterus, adult, pool1	10100-102D1	175.58	41.29	6.14	0.34	5.12	3.07	0.17	0.85	0.00
uterus, fetal, donor1	10055-101H1	28.67	9.21	8.70	1.54	4.10	1.02	0.51	1.02	0.51
vagina, adult	10204-103F6	862.03	91.76	14.22	6.46	15.51	0.65	1.94	1.29	0.00
vein, adult	10191-103E2	334.50	39.67	8.55	6.36	3.29	2.41	0.66	0.44	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	5.61	4.81	1.34	0.00	1.07	1.34	0.27	0.00	0.00